{"gene":"RASGRP1","run_date":"2026-04-28T19:45:45","timeline":{"discoveries":[{"year":1998,"finding":"RasGRP1 was characterized as a guanine nucleotide exchange factor (GEF) for Ras with a catalytic domain, an atypical pair of EF hands that bind calcium, and a diacylglycerol (DAG)-binding C1 domain. DAG/phorbol ester binding recruits RasGRP1 to the membrane fraction, and deletion of the DAG-binding domain abolished sustained Ras-ERK signaling and membrane partitioning.","method":"cDNA characterization, domain deletion mutagenesis, cellular fractionation, Ras-ERK signaling assays, fibroblast transformation assay","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — original biochemical characterization with domain mutagenesis and multiple functional readouts, foundational paper with 565 citations","pmids":["9582122"],"is_preprint":false},{"year":1998,"finding":"The C1 domain of RasGRP1 (or membrane-localizing prenylation signal replacing it) is required for transforming activity and MAP kinase activation; a point mutation in the catalytic domain preventing Ras interaction abolishes transformation; the C1 domain mediates translocation to cell membranes in response to phorbol ester or serum stimulation.","method":"Point mutagenesis, domain deletion, NIH 3T3 transformation assay, MAP kinase activation assay, membrane translocation imaging","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis of catalytic and C1 domains with multiple orthogonal functional assays","pmids":["9819387"],"is_preprint":false},{"year":2000,"finding":"RasGRP1 links T cell receptor (TCR) signaling to Ras activation downstream of PLCγ1 and DAG. Antibodies against RasGRP1 inhibited Ras-guanyl nucleotide exchange activity in membranes from TCR-stimulated Jurkat cells; a PLCγ1 inhibitor reduced Ras activation; overexpression of RasGRP1 enhanced TCR-Ras-ERK signaling and IL-2 secretion.","method":"Inhibitory antibody experiments, PLCγ1 inhibitor treatment, overexpression in T cells, Ras activation assays, IL-2 secretion assay","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (antibody inhibition, pharmacological inhibition, overexpression) in T cells","pmids":["10807788"],"is_preprint":false},{"year":2000,"finding":"RasGRP1 is essential for thymocyte differentiation: RasGRP1-null mice have normal immature thymocyte numbers but a marked deficiency of mature single-positive thymocytes, and mutant thymocytes completely lack Ras signaling and proliferation in response to DAG analogs or TCR stimulation.","method":"RasGRP1 knockout mouse model, thymocyte phenotyping (flow cytometry), Ras signaling and proliferation assays","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — clean genetic KO with specific cellular phenotype, replicated by multiple labs","pmids":["11017103"],"is_preprint":false},{"year":2000,"finding":"RasGRP1's C1 domain binds phorbol esters and DAG with high affinity (Kd ~0.58 nM for [3H]PDBu), similar to PKC; calcium does not affect phorbol ester binding; acidic phospholipid requirements differ from PKC.","method":"Radioligand binding assay ([3H]PDBu), competition binding with phorbol ester analogs and bryostatin 1","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro binding assay with rigorous pharmacological characterization","pmids":["10779365"],"is_preprint":false},{"year":2003,"finding":"In response to Src-dependent activation of PLCγ1, RasGRP1 translocates to the Golgi apparatus where it activates Ras. Ca2+ positively regulates Ras on the Golgi through RasGRP1 while negatively regulating Ras on the plasma membrane via CAPRI. Ras activation after TCR stimulation in Jurkat cells (rich in RasGRP1) is limited to the Golgi.","method":"Live-cell imaging of RasGRP1 translocation, Ras activation assays at specific compartments, Src inhibition, Ca2+ manipulation, Jurkat T cell TCR stimulation","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including compartment-specific Ras assays and live imaging, replicated context","pmids":["12845332"],"is_preprint":false},{"year":2003,"finding":"Members of the RasGRP family (including RasGRP1) are the only Ras activators that localize to the Golgi and can induce GTP loading of Ras at the Golgi; Ras activation at the plasma membrane can be achieved by most Ras activators but Golgi-specific Ras activation requires RasGRPs.","method":"Subcellular distribution assays, compartment-specific Ras activation assays in cells expressing various GEFs","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — systematic comparison of multiple GEFs for compartment-specific Ras activation","pmids":["12782630"],"is_preprint":false},{"year":2002,"finding":"DGKα (diacylglycerol kinase alpha) acts as a negative modulator of RasGRP1 signaling by metabolizing DAG; expression of catalytically inactive DGKα leads to sustained DAG accumulation, sustained RasGRP1 membrane translocation, and sustained MAPK activation downstream of TCR.","method":"Expression of kinase-dead DGKα, DAG measurement, RasGRP1 membrane translocation assay, MAPK activation assay in T cells","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 — catalytic mutant and biochemical assays establishing DAG as the key regulator of RasGRP1 membrane recruitment","pmids":["11919165"],"is_preprint":false},{"year":2004,"finding":"The C1 domains of RasGRP1 and PKCθ show specific localization within T cells and distinct responses to pharmacological stimulation and TCR triggering, reflecting their binding to different DAG pools at distinct subcellular locations (plasma membrane vs. internal membranes); overexpression of C1 domains can attenuate DAG-dependent Ras activation signals from specific compartments.","method":"Live-cell imaging of GFP-tagged C1 domains in Jurkat T cells, pharmacological stimulation, TCR triggering, Ras activation assays","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — live imaging with functional consequence (Ras activation attenuation) in living T cells","pmids":["15064353"],"is_preprint":false},{"year":2005,"finding":"RasGRP1 is required for optimal antigen receptor-triggered Ras-ERK activation in T cells via its DAG-binding domain; phosphorylation of threonine 184 in RasGRP1 (driven by novel PKC kinases) correlates with ERK activation; active PKCθ requires RasGRP1 sufficiency to trigger downstream events, defining a DAG-PKC-RasGRP1-Ras-ERK pathway distinct from SOS-mediated activation.","method":"RasGRP1-deficient Jurkat T-cell clone, RNAi knockdown, domain mutagenesis (DAG-binding domain), phosphorylation analysis, ERK activation assays, genetic epistasis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal approaches including genetic KO clone, RNAi, mutagenesis, and phosphorylation mapping","pmids":["15899849"],"is_preprint":false},{"year":2007,"finding":"RasGRP1 orchestrates Ras signaling in lymphocytes in two ways: (i) by directly activating Ras, and (ii) by facilitating priming of SOS with Ras-GTP that binds SOS's allosteric pocket, creating a positive RasGTP-SOS feedback loop that functions as a rheostat. Without RasGRP1, initiation of this SOS feedback loop is impaired, explaining RasGRP1 dominance over SOS.","method":"T- and B-cell line genetic manipulation, SOS allosteric mutants, RasGTP measurement, active Ras-like molecule (RasV12C40) rescue experiment","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — mechanistic epistasis with allosteric mutants and rescue experiments establishing the RasGRP1-SOS feedback loop","pmids":["17283063"],"is_preprint":false},{"year":2007,"finding":"Vav1 transduces TCR signals to Ras-ERK by controlling membrane recruitment of RasGRP1 (via PLCγ1 activation) and recruitment of Sos1/2 to LAT; Vav1 is required for TCR-induced LAT phosphorylation, which is a key upstream event for PLCγ1 activation and subsequent RasGRP1 membrane recruitment.","method":"Genetic KO of Vav1, epistasis analysis, membrane recruitment assays, LAT phosphorylation analysis in double-positive thymocytes","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — clean genetic KO with mechanistic pathway placement showing Vav1→LAT→PLCγ1→RasGRP1","pmids":["14764585"],"is_preprint":false},{"year":2007,"finding":"RasGRP1 regulation by B cell antigen receptor (BCR) requires cooperativity between three domains: the C1 domain (binds DAG from BCR-coupled PLCγ2), the Plasma membrane Targeter (PT) domain (sufficient and essential for plasma membrane targeting), and the Suppressor of PT (SuPT) domain (attenuates PT activity, preventing constitutive plasma membrane localization). DAG binding by C1 counteracts SuPT, enabling translocation.","method":"Domain deletion and mutation analysis, BCR ligation, live-cell imaging of RasGRP1 translocation, subcellular fractionation in B cell lines","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — systematic domain dissection with multiple deletion mutants and live imaging","pmids":["17567957"],"is_preprint":false},{"year":2009,"finding":"The EF1 hand of RasGRP1 is required for receptor-induced translocation to the plasma membrane in B cell lines by counteracting the SuPT domain; EF1-mediated translocation does not involve antigen receptor-induced Ca2+ flux but is regulated by alternative splicing. The Ras-binding site in the catalytic GEF domain is required for both PT-mediated plasma membrane targeting and C1-mediated endomembrane localization, suggesting positive feedback between the GEF domain and membrane-binding domains.","method":"EF1 mutagenesis, alternative splicing analysis, Ca2+ chelation, subcellular localization assays in B cell lines, GEF domain mutagenesis","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 2 — systematic mutagenesis of multiple regulatory elements with mechanistic follow-up","pmids":["19168098"],"is_preprint":false},{"year":2011,"finding":"Phosphoinositide 3-kinase (PI3K) signaling generates phosphoinositides that are directly detected by a basic/hydrophobic cluster within the plasma membrane-targeting domain of RasGRP1, providing a novel mechanism for plasma membrane targeting that cooperates with DAG detection by the C1 domain; this couples PI3K and RAS signaling.","method":"Phospholipid vesicle binding assay, PI3K inhibition, BCR ligation, point mutagenesis of basic/hydrophobic cluster, subcellular localization assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro phospholipid binding assay plus mutagenesis and cellular localization experiments","pmids":["21285350"],"is_preprint":false},{"year":2011,"finding":"A Ca2+-driven, PKCδ- and RasGRP1-dependent pathway activates ERK in a proapoptotic manner during B cell development; this pathway is biochemically distinct from DAG-driven ERK activation and depends on STIM1 concentration controlling Ca2+ entry magnitude.","method":"PKCδ knockout mice, genetic epistasis, Ca2+ flux manipulation, STIM1 overexpression, ERK activation assays in B cells","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — genetic KO + epistasis + multiple orthogonal methods establishing a Ca2+-PKCδ-RasGRP1-ERK proapoptotic pathway","pmids":["21441934"],"is_preprint":false},{"year":2013,"finding":"Crystal structure of an autoinhibited fragment of RasGRP1 revealed that the Ras-binding site is blocked by an interdomain linker and the membrane-interaction surface is hidden within a dimerization interface stabilized by the C-terminal oligomerization domain. NMR data showed Ca2+ binding to the regulatory module generates conformational changes incompatible with the inactive assembly, establishing a structural basis for activation by Ca2+ and membrane-localization signals.","method":"X-ray crystallography, NMR spectroscopy, functional domain mutagenesis","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1 — crystal structure plus NMR with mechanistic validation, strong structural evidence","pmids":["23908768"],"is_preprint":false},{"year":2016,"finding":"Human RASGRP1 deficiency causes immunodeficiency with impaired ERK phosphorylation in T and B cells (rescued by wild-type RASGRP1 expression), defective proliferation, activation and motility; NK cell cytotoxicity was impaired due to defective granule convergence and actin accumulation. Interaction proteomics identified dynein light chain DYNLL1 as a RASGRP1-interacting protein linking it to cytoskeletal dynamics; RASGRP1-deficient cells showed decreased RhoA GTPase activation.","method":"Homozygosity mapping, exome sequencing, RASGRP1 rescue by wild-type expression, interaction proteomics, RhoA activation assay, NK cell cytotoxicity assay, live-cell imaging","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — human patient genetics with functional rescue, interaction proteomics, and multiple cellular phenotype assays","pmids":["27776107"],"is_preprint":false},{"year":2017,"finding":"His 212 in RasGRP1 acts as a pH sensor that alters signaling activity and plasma membrane recruitment by modulating the balance between inactive and active conformations; structural comparison of autoinhibited RasGRP1 with active RasGRP4:H-Ras and RasGRP2:Rap1b complexes revealed that the transition from inactive to active involves rearrangement of an inter-domain linker at His 212, which displaces inhibitory inter-domain interactions.","method":"SNP variant analysis, RasGRP1 crystal structure comparison, plasma membrane recruitment assays, signaling activity assays with His212 mutants","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1 — structural analysis combined with functional validation of pH-sensitive conformational switch","pmids":["28952923"],"is_preprint":false},{"year":2007,"finding":"SKAP55 co-immunoprecipitates with RasGRP1 via its C-terminus in a tyrosine phosphorylation-enhanced manner; SKAP55 modulates TCR signaling to Ras-ERK-AP1 by binding RasGRP1, and loss of this binding abolishes SKAP55-mediated inhibition of ERK and ELK activation.","method":"Co-immunoprecipitation, RNAi knockdown, overexpression, reporter gene assays in primary human T cells and Jurkat cells","journal":"Molecular immunology","confidence":"Medium","confidence_rationale":"Tier 3 — Co-IP plus functional follow-up, single lab","pmids":["17658605"],"is_preprint":false},{"year":2011,"finding":"SDF-1 (CXCL12) stimulation induces formation of a molecular signaling complex containing RasGRP1, Gαi2, and ZAP-70, causing RasGRP1 to localize to the plasma membrane (activating K-Ras) and Golgi (activating N-Ras); SDF-1-dependent RasGRP1 localization does not require its DAG-binding domain (unlike antigen receptor stimulation) but requires TCR expression, Gi proteins, and ZAP-70.","method":"RasGRP1 knockdown (RNAi), co-immunoprecipitation, subcellular localization assays, compartment-specific Ras activation assays, Gi inhibition (pertussis toxin), ZAP-70 inhibition in human T cells","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including co-IP, compartment-specific Ras assays, and targeted inhibition","pmids":["21856938"],"is_preprint":false},{"year":2007,"finding":"RasGRP1 stimulation by phorbol ester (TPA) regulates the sodium-chloride cotransporter (NCC) surface expression through a PKC-independent, RasGRP1-ERK pathway: gene silencing of RasGRP1 prevented PE-mediated suppression of NCC activity, H-Ras activation, and ERK1/2 activation.","method":"RasGRP1 gene silencing (siRNA), thiazide-sensitive 22Na+ uptake assay, biotinylation assay, PKC inhibitors, MAPK inhibitors, H-Ras activation assay in mDCT cells","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 — genetic silencing with pharmacological controls and multiple functional readouts","pmids":["18077438"],"is_preprint":false},{"year":2010,"finding":"RasGRP1 stimulation enhances ubiquitination and dynamin-dependent endocytosis of NCC; MEK1/2 inhibitors and RasGRP1 gene silencing blocked NCC ubiquitination, and inhibition of ubiquitination prevented PE-mediated decrease in NCC surface expression and activity.","method":"Biotinylation/internalization assays, dominant-negative dynamin construct, NCC immunoprecipitation/ubiquitin immunoblotting, RasGRP1 siRNA, radiotracer uptake assay","journal":"American journal of physiology. Renal physiology","confidence":"High","confidence_rationale":"Tier 2 — multiple complementary assays (dominant negative, siRNA, biochemical) establishing mechanism","pmids":["20392800"],"is_preprint":false},{"year":2010,"finding":"The transcription factor Gfi1 promotes RasGRP1 expression and RasGRP1 is required for G-CSF-induced Ras/MEK/ERK signaling and neutrophil differentiation; Gfi1-null myeloid cells have reduced RasGRP1 protein and are selectively defective at G-CSF-induced ERK1/2 activation; expression of RasGRP1 in Gfi1-deficient cells rescues ERK activation and neutrophil maturation.","method":"Gfi1 knockout mice, RasGRP1 mRNA/protein quantification, Gfi1 transduction in myeloid cells, G-CSF stimulation assays, RasGRP1 re-expression rescue experiment","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — genetic KO plus rescue experiment establishing Gfi1→RasGRP1→G-CSF-ERK axis","pmids":["20203268"],"is_preprint":false},{"year":2006,"finding":"RasGRP1 plays an essential role in FcεRI-mediated PI3K activation in mast cells; RasGRP1-deficient mice failed to mount anaphylactic reactions; RasGRP1-/- mast cells had reduced degranulation, cytokine production, PI3K/Akt activation, and impaired granule translocation, microtubule formation, and RhoA activation; constitutively active N-Ras rescued degranulation and Akt activation.","method":"RasGRP1 knockout mice, passive systemic anaphylaxis assay, mast cell degranulation assay, PI3K/Akt activation assays, rescue with constitutively active N-Ras, RhoA activation assay","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — clean genetic KO with multiple phenotypic readouts and N-Ras rescue","pmids":["17190838"],"is_preprint":false},{"year":2009,"finding":"In B cells, DAG analogue-stimulated RasGRP-Ras-Raf-MEK-ERK signaling leads to phosphorylation of proapoptotic BH3-only protein Bim by ERK; in vitro, Bim is phosphorylated by ERK on sites associated with increased apoptotic activity. Apoptosis in Toledo B-NHL cells can be suppressed by Bim downregulation or Bcl-2 overexpression.","method":"Biochemical signaling assays, in vitro ERK kinase assay with Bim substrate, Bim siRNA, Bcl-2 overexpression, Bak-Bax complex assay, mitochondrial membrane permeability assay","journal":"Experimental hematology","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay plus cellular genetic manipulation establishing RasGRP-ERK-Bim apoptotic pathway","pmids":["19100522"],"is_preprint":false},{"year":2012,"finding":"The unique C-terminal tail domain (~200 residues) of RasGRP1 is required for its membrane trafficking in response to TCR stimulation; tail-deleted RasGRP1 cannot traffic to the cell membrane following stimulation and cannot activate ERK; knock-in mice lacking the tail domain show aberrant thymic selection and CD4+ T cell expansion with autoantibody production.","method":"Knock-in mouse with tail domain deletion, thymocyte phenotyping, ERK activation assays, membrane localization assays after TCR stimulation","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — knock-in mouse model with mechanistic demonstration of impaired membrane trafficking","pmids":["22719950"],"is_preprint":false},{"year":2016,"finding":"HDAC inhibitors cause acetylation of HSP90, releasing and degrading the HSP90 client proteins RASGRP1 and CRAF, leading to downregulation of MAPK pathway signaling and upregulation of pro-apoptotic BIM; RASGRP1 siRNA mimics HDAC inhibitor pro-apoptotic effects; RASGRP1 is identified as a novel HSP90 client protein.","method":"HSP90 co-immunoprecipitation, RASGRP1 siRNA, constitutively active MEK1 overexpression, BIM siRNA, in vitro and in vivo lymphoma cell assays","journal":"Leukemia","confidence":"High","confidence_rationale":"Tier 2 — Co-IP establishing HSP90-RASGRP1 interaction plus multiple genetic perturbations defining pathway","pmids":["27890930"],"is_preprint":false},{"year":2015,"finding":"RasGRP1 and SOS1 lie downstream of EGFR but act in functional opposition in intestinal epithelial cells; RasGRP1 creates a negative feedback loop limiting proliferative EGFR-SOS1-Ras signals; genetic Rasgrp1 depletion in mice with KRas activating mutation or Apc mutation exacerbates Ras-ERK signaling and cell proliferation.","method":"RasGRP1 knockout mice, KRas and Apc mutant mouse crosses, Ras-ERK signaling assays, cell proliferation assays in intestinal crypts","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis in multiple mouse models establishing RasGRP1 as a negative feedback regulator of EGFR-SOS1-Ras","pmids":["26005835"],"is_preprint":false},{"year":2015,"finding":"Overexpression of RasGRP1 in T-ALL results in constitutively high GTP-loading rate of Ras (increased flux through RasGTP/GDP cycle) rather than static RasGTP accumulation as in KRAS(G12D); IL-2/7/9 stimulation activates Erk and Akt downstream of Ras in RasGRP1-overexpressing T-ALL relying on baseline DAG levels (not acute PLCγ activation), and IL-2/7/9 likely decrease RasGAP activity.","method":"Three distinct Ras GTP/GDP cycle assays, PLCγ inhibition, IL-2/7/9 stimulation assays, comparison with KRAS(G12D) T-ALL cells","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 — three orthogonal assays measuring different aspects of Ras cycle with mechanistic comparison to KRAS oncogene","pmids":["26549032"],"is_preprint":false},{"year":2016,"finding":"RasGRP1 promotes amphetamine-induced motor behavior through interaction with Rhes in the striatum; RasGRP1 stabilizes Rhes and increases its synaptic accumulation; depletion of RasGRP1 attenuates the enhanced locomotor response to amphetamine in partially Rhes-deficient mice; RasGRP1 affects the composition of the amphetamine-induced Rhes interactome.","method":"RasGRP1/Rhes knockout mouse crosses, locomotor behavior assay, proteomic analysis of striatal lysates (Rhesactome), synaptic fractionation","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis in mice plus proteomics establishing RasGRP1-Rhes interaction and functional consequence","pmids":["27902448"],"is_preprint":false},{"year":2020,"finding":"RasGRP1 is a causal factor in L-DOPA-induced dyskinesia (LID); L-DOPA rapidly up-regulates RasGRP1 in striatum of mouse and macaque PD models; RasGRP1 knockout dramatically diminishes LID without interfering with L-DOPA therapeutic effects; RasGRP1 acts as a GEF for Rheb (activator of mTOR) in addition to Ras, promoting L-DOPA-induced ERK and mTOR signaling in striatum.","method":"RasGRP1 knockout mice, macaque PD model, L-DOPA-induced dyskinesia scoring, ERK and mTOR signaling assays, high-resolution tandem mass spectrometry for downstream targets","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 — genetic KO in two animal models with mechanistic identification of Rheb as substrate","pmids":["32426479"],"is_preprint":false},{"year":2018,"finding":"SRSF1 directly binds exon 11 of RASGRP1 mRNA (via oligonucleotide-protein pulldown assay) and controls its alternative splicing; silencing SRSF1 in human T cells increases alternatively spliced (exon 11-skipping) RasGRP1 isoforms and decreases RasGRP1 protein; SRSF1 overexpression in SLE T cells recovers RasGRP1 expression, which in turn induces DNMT1/IL-2 expression.","method":"Oligonucleotide-protein pulldown assay, SRSF1 siRNA, SRSF1 overexpression, qPCR and Western blot for RasGRP1 isoforms in human T cells","journal":"Arthritis & rheumatology","confidence":"High","confidence_rationale":"Tier 2 — direct RNA-binding pulldown assay plus functional genetic manipulation establishing SRSF1→RasGRP1 splicing regulation","pmids":["29905030"],"is_preprint":false},{"year":2012,"finding":"In LAT-Y136F mutant mice where PLCγ1 binding to LAT is lost, RasGRP1 (not Sos1 or Sos2) is the major Ras GEF responsible for ERK activation and the lymphoproliferative phenotype, operating through a PLCγ1-independent pathway requiring Lck/Fyn, PKCθ, and RasGRP1 downstream of a Zap70-independent LAT pathway.","method":"Genetic analysis in LAT-Y136F mice, crosses with RasGRP1 KO, Sos1/Sos2 KO mice; kinase inhibitor experiments; ERK activation assays","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis across multiple KO mouse models identifying RasGRP1 as the dominant GEF in this context","pmids":["23209318"],"is_preprint":false},{"year":2019,"finding":"The transcription factor RUNX1 (with CBFB) directly regulates RASGRP1 transcription through an intronic enhancer; CRISPR-Cas9 disruption of this enhancer reduces RasGRP1 expression and RUNX1/CBFB binding; hnRNP-K binds to the SLE risk allele of rs11631591 in this enhancer in an allele-dependent manner and modulates RASGRP1 expression in T cells.","method":"CRISPR-Cas9 enhancer disruption, EMSA, mass spectrometry, ChIP-qPCR, luciferase reporter assays, hnRNP-K inhibition in Jurkat and primary T cells","journal":"Frontiers in immunology","confidence":"High","confidence_rationale":"Tier 2 — CRISPR disruption plus multiple orthogonal methods (EMSA, MS, ChIP) establishing enhancer mechanism","pmids":["31164884"],"is_preprint":false},{"year":2020,"finding":"RUNX1 transcriptionally regulates RASGRP1; diminished Rasgrp1 expression causes defective T lymphocyte selection and inflammatory disease whose severity inversely correlates with Rasgrp1 levels; H3K27 acetylation profiling identified a RASGRP1 enhancer harboring autoimmunity-associated SNPs with RUNX1/CBFB binding.","method":"Mouse models with graded Rasgrp1 expression, H3K27 acetylation ChIP, RUNX1 expression analysis in patient T cells, CRISPR disruption","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — ChIP, patient studies, and mouse genetic models establishing RUNX1-RASGRP1 transcriptional circuit","pmids":["33065764"],"is_preprint":false},{"year":2004,"finding":"RasGRP1 elevates apoptosis of immature B cells (WEHI-231) upon BCR ligation through down-regulation of NF-κB and Bcl-xL in a manner independent of ERK1/2; a dominant negative RasGRP1 mutant suppresses BCR-induced apoptosis.","method":"RasGRP1 overexpression, dominant negative RasGRP1 mutant, BCR ligation, NF-κB reporter, Bcl-xL immunoblot, apoptosis assay, NF-κB inhibition","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — gain- and loss-of-function with identification of downstream effectors (NF-κB, Bcl-xL)","pmids":["14970203"],"is_preprint":false},{"year":2011,"finding":"PTH suppresses NCC function via a PLC/RasGRP1/ERK pathway: PLC inhibition prevented PTH effect; gene silencing of RasGRP1 prevented PTH-mediated NCC activity suppression, H-Ras activation, and ERK1/2 activation; PKC and PKA inhibitors had no effect, establishing a PKC-independent pathway.","method":"RasGRP1 gene silencing, PTH stimulation, PLC inhibitor, PKC/PKA inhibitors, MAPK inhibitor, 22Na+ uptake assay, H-Ras and ERK activation assays","journal":"Translational research","confidence":"High","confidence_rationale":"Tier 2 — siRNA plus pharmacological controls defining PTH→PLC→RasGRP1→ERK→NCC pathway","pmids":["22005268"],"is_preprint":false}],"current_model":"RASGRP1 is a DAG/Ca2+-regulated Ras guanine nucleotide exchange factor that, upon membrane recruitment via its C1 (DAG-binding), PT, and EF-hand domains (regulated by PI3K-generated phosphoinositides), activates Ras at the plasma membrane and Golgi to drive ERK/MAPK signaling; in lymphocytes it is essential for TCR/BCR-triggered Ras-ERK activation (acting upstream of and in positive feedback with SOS), thymocyte development, and NK/mast cell effector functions, while its autoinhibition involves an interdomain linker blocking the Ras-binding site and a dimerization interface masking the membrane-interaction surface, both relieved by Ca2+ and membrane-localization signals."},"narrative":{"teleology":[{"year":1998,"claim":"Identification of RASGRP1 as a DAG-responsive Ras GEF resolved how lipid second messengers directly activate Ras independently of receptor tyrosine kinase–SOS pathways, establishing a new signaling paradigm.","evidence":"cDNA characterization, domain deletion mutagenesis, cellular fractionation, Ras-ERK assays, and fibroblast transformation assays","pmids":["9582122","9819387"],"confidence":"High","gaps":["Endogenous substrates beyond H-Ras not yet defined","Regulation by calcium through EF hands not yet mechanistically resolved"]},{"year":2000,"claim":"Genetic knockout and antibody-inhibition studies established that RASGRP1 is the essential Ras GEF linking TCR/PLCγ1–generated DAG to Ras-ERK activation in thymocytes, explaining the long-standing gap between TCR engagement and Ras activation.","evidence":"RasGRP1-null mice with thymocyte phenotyping; inhibitory antibodies and PLCγ1 inhibitors in Jurkat T cells; high-affinity C1 domain binding measured by radioligand assay","pmids":["11017103","10807788","10779365"],"confidence":"High","gaps":["Whether RASGRP1 and SOS cooperate or compete in physiological TCR signaling unknown","Compartment-specific Ras activation not yet explored"]},{"year":2003,"claim":"Discovery that RASGRP1 activates Ras specifically at the Golgi apparatus (and not plasma membrane) after TCR stimulation revealed that Ras signaling is compartmentalized, with Ca²⁺ positively regulating Golgi-Ras and negatively regulating plasma membrane-Ras.","evidence":"Live-cell imaging of RASGRP1 translocation, compartment-specific Ras activation assays, Ca²⁺ manipulation in Jurkat T cells; systematic GEF comparison across compartments","pmids":["12845332","12782630"],"confidence":"High","gaps":["How DAG and Ca²⁺ signals are spatially segregated between Golgi and plasma membrane not fully resolved","Functional consequences of Golgi-specific vs. plasma membrane Ras signaling on downstream gene expression unclear"]},{"year":2004,"claim":"RASGRP1 was shown to promote BCR-induced apoptosis in immature B cells through NF-κB/Bcl-xL downregulation independently of ERK, revealing a pro-apoptotic function relevant to B cell tolerance.","evidence":"Overexpression and dominant-negative mutant of RasGRP1, NF-κB reporter assays, Bcl-xL immunoblot, apoptosis assays in WEHI-231 B cells","pmids":["14970203"],"confidence":"High","gaps":["The Ras-independent mechanism by which RASGRP1 suppresses NF-κB not identified","Physiological relevance to in vivo B cell selection not tested"]},{"year":2005,"claim":"Phosphorylation of Thr184 by novel PKCs was identified as a key regulatory input, and DAG-PKC-RASGRP1 was placed as a pathway parallel to SOS, resolving how two distinct GEF arms cooperate downstream of TCR.","evidence":"RasGRP1-deficient Jurkat clone, RNAi, domain mutagenesis, phosphorylation mapping, ERK activation assays","pmids":["15899849"],"confidence":"High","gaps":["Structural basis for PKC-mediated Thr184 phosphorylation effect unknown","Whether Thr184 phosphorylation is required in vivo not tested"]},{"year":2007,"claim":"The discovery that RASGRP1-generated Ras-GTP primes the allosteric site of SOS established a positive-feedback amplification loop, explaining why RASGRP1 dominates over SOS in lymphocyte Ras activation and providing a mechanistic basis for digital/analog Ras signaling responses.","evidence":"SOS allosteric mutants, RasGTP measurement, RasV12C40 rescue in T and B cell lines","pmids":["17283063"],"confidence":"High","gaps":["Quantitative parameters of the feedback loop (thresholds, kinetics) not measured in primary cells","Whether this loop operates identically in B versus T cells unknown"]},{"year":2007,"claim":"Systematic domain dissection in B cells identified the PT domain as essential for plasma membrane targeting and the SuPT domain as an intramolecular brake, establishing that RASGRP1 membrane recruitment requires cooperative relief of autoinhibition by DAG and the PT/EF-hand modules.","evidence":"Domain deletion/mutation analysis, live-cell imaging of RASGRP1 translocation after BCR ligation in B cell lines; Vav1 KO epistasis defining upstream pathway","pmids":["17567957","14764585"],"confidence":"High","gaps":["Structural basis of SuPT-mediated inhibition not resolved at atomic level","Whether SuPT regulation differs between T and B cells not tested"]},{"year":2007,"claim":"Beyond immune cells, RASGRP1 was found to mediate phorbol ester– and PTH-induced suppression of the renal sodium-chloride cotransporter NCC via H-Ras-ERK signaling, expanding RASGRP1 function to epithelial ion transport regulation.","evidence":"RasGRP1 siRNA, thiazide-sensitive ²²Na⁺ uptake, H-Ras and ERK assays, PKC inhibitor controls in mDCT cells","pmids":["18077438","20392800","22005268"],"confidence":"High","gaps":["Whether RASGRP1 regulation of NCC is physiologically relevant in vivo not demonstrated","Mechanism connecting ERK activation to NCC ubiquitination not fully defined"]},{"year":2011,"claim":"PI3K-generated phosphoinositides were identified as direct ligands of the RASGRP1 PT domain, establishing a novel PI3K-RAS signaling cross-talk mechanism that cooperates with DAG sensing for membrane targeting.","evidence":"Phospholipid vesicle binding assay, PI3K inhibition, point mutagenesis of basic/hydrophobic cluster, subcellular localization in B cells","pmids":["21285350"],"confidence":"High","gaps":["Which specific phosphoinositide species are preferred in vivo not determined","Whether PI3K-PT interaction is regulated by Ca²⁺ or phosphorylation unknown"]},{"year":2011,"claim":"A Ca²⁺-driven, PKCδ-dependent pathway through RASGRP1 was shown to activate proapoptotic ERK signaling during B cell development, distinguishing Ca²⁺-triggered from DAG-triggered RASGRP1 activation modes and linking RASGRP1 to B cell negative selection.","evidence":"PKCδ knockout mice, STIM1 overexpression, Ca²⁺ flux manipulation, ERK assays in developing B cells","pmids":["21441934"],"confidence":"High","gaps":["How Ca²⁺ and PKCδ mechanistically converge on RASGRP1 at the molecular level unclear","Whether this pathway operates in human B cell development not tested"]},{"year":2013,"claim":"The crystal structure of autoinhibited RASGRP1 revealed the atomic mechanism of autoinhibition: an interdomain linker blocks the Ras-binding site and dimerization buries the membrane-interaction surface; Ca²⁺ binding induces conformational changes incompatible with this inactive assembly, providing a structural framework for activation.","evidence":"X-ray crystallography, NMR spectroscopy, functional domain mutagenesis","pmids":["23908768"],"confidence":"High","gaps":["Structure of the fully active, membrane-bound RASGRP1-Ras complex not determined","How DAG binding cooperates structurally with Ca²⁺-induced conformational change not visualized"]},{"year":2015,"claim":"In intestinal epithelial cells, RASGRP1 was found to oppose SOS1-driven proliferative Ras-ERK signaling, functioning as a negative feedback regulator downstream of EGFR — a role opposite to its activating function in lymphocytes — with genetic depletion exacerbating tumorigenesis in KRas and Apc mutant mice.","evidence":"RasGRP1 knockout mice crossed with KRas and Apc mutant mice, Ras-ERK signaling and proliferation assays in intestinal crypts","pmids":["26005835"],"confidence":"High","gaps":["Molecular basis for how RASGRP1 generates negative feedback (competition with SOS, substrate selectivity?) not defined","Whether this tumor-suppressive role extends to other epithelia unknown"]},{"year":2016,"claim":"Human RASGRP1 deficiency was identified as a cause of combined immunodeficiency, with impaired T cell, B cell, and NK cell function including defective ERK phosphorylation and granule convergence; DYNLL1 was identified as a physical interactor linking RASGRP1 to cytoskeletal dynamics and RhoA activation.","evidence":"Homozygosity mapping, exome sequencing, wild-type rescue, interaction proteomics, RhoA activation and NK cytotoxicity assays","pmids":["27776107"],"confidence":"High","gaps":["Full spectrum of clinical phenotype across patients not established","Mechanism by which RASGRP1-DYNLL1 interaction regulates granule convergence not resolved"]},{"year":2017,"claim":"His212 was identified as a pH sensor controlling the balance between autoinhibited and active conformations, providing a structural mechanism for environmental pH regulation of RASGRP1 signaling.","evidence":"SNP variant analysis, crystal structure comparison with active RasGRP4:H-Ras complex, plasma membrane recruitment and signaling assays with His212 mutants","pmids":["28952923"],"confidence":"High","gaps":["Physiological contexts where pH fluctuations regulate RASGRP1 not identified","Whether pH sensing cooperates with Ca²⁺ and DAG inputs not tested"]},{"year":2019,"claim":"RUNX1/CBFB was established as a direct transcriptional regulator of RASGRP1 through an intronic enhancer harboring autoimmunity-associated SNPs, connecting genetic risk for SLE to RASGRP1 expression levels in T cells.","evidence":"CRISPR-Cas9 enhancer disruption, EMSA, ChIP-qPCR, mass spectrometry identifying hnRNP-K, luciferase reporters in Jurkat and primary T cells; mouse models with graded Rasgrp1 expression","pmids":["31164884","33065764"],"confidence":"High","gaps":["Whether additional transcription factors beyond RUNX1 and hnRNP-K regulate this enhancer unknown","Causal link from SNP to SLE pathogenesis through RASGRP1 dosage not demonstrated in patients"]},{"year":2020,"claim":"RASGRP1 was shown to function as a GEF for Rheb (in addition to Ras), activating mTOR signaling in striatal neurons and causally driving L-DOPA–induced dyskinesia, extending RASGRP1 substrate range beyond classical Ras GTPases.","evidence":"RasGRP1 knockout mice and macaque PD models, L-DOPA dyskinesia scoring, ERK and mTOR signaling assays, mass spectrometry","pmids":["32426479"],"confidence":"High","gaps":["Biochemical GEF activity toward Rheb not reconstituted in vitro with purified proteins","Whether Rheb is a physiological substrate in immune cells not tested"]},{"year":null,"claim":"Key unresolved questions include the full-length structure of active membrane-bound RASGRP1 in complex with Ras, the quantitative integration of DAG/Ca²⁺/PI3K/pH inputs into a unified activation model, the molecular basis for context-dependent tumor-suppressive versus oncogenic roles, and whether Rheb GEF activity is a general or tissue-specific function.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structure of full-length active RASGRP1 on membranes","Quantitative signaling model integrating all regulatory inputs absent","Rheb GEF activity not biochemically reconstituted in vitro"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,2,10,28]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[0,4,14]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[5,6,20]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,12,14,20]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,2,5,9,10,15,28,29,31]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[3,11,17,24,33]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[15,25,36]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[3,26]}],"complexes":[],"partners":["SOS1","DYNLL1","RHES","SKAP55","HSP90","ZAP70"],"other_free_text":[]},"mechanistic_narrative":"RASGRP1 is a diacylglycerol (DAG)- and calcium-regulated guanine nucleotide exchange factor (GEF) for Ras family GTPases that couples receptor-generated lipid second messengers to Ras-ERK/MAPK signaling, with essential roles in lymphocyte development, immune effector function, and neuronal signaling. Membrane recruitment is governed by cooperative engagement of its C1 domain with DAG, a plasma membrane-targeting (PT) domain that senses PI3K-generated phosphoinositides, and EF-hand–mediated conformational changes; autoinhibition involves an interdomain linker occluding the Ras-binding site and a dimerization interface masking the membrane-interaction surface, both relieved by Ca²⁺ and membrane localization [PMID:9582122, PMID:23908768, PMID:21285350, PMID:17567957]. In T and B cells, RASGRP1 is the dominant Ras GEF downstream of antigen receptor–activated PLCγ, and it primes SOS-mediated positive feedback amplification of Ras-GTP; loss of RASGRP1 blocks thymocyte positive selection, impairs NK cell cytotoxicity, abolishes mast cell degranulation, and causes human immunodeficiency [PMID:11017103, PMID:17283063, PMID:27776107, PMID:17190838]. Beyond classical Ras, RASGRP1 acts as a GEF for Rheb to activate mTOR signaling in striatal neurons, where it is a causal mediator of L-DOPA–induced dyskinesia [PMID:32426479]."},"prefetch_data":{"uniprot":{"accession":"O95267","full_name":"RAS guanyl-releasing protein 1","aliases":["Calcium and DAG-regulated guanine nucleotide exchange factor II","CalDAG-GEFII","Ras guanyl-releasing protein"],"length_aa":797,"mass_kda":90.4,"function":"Functions as a calcium- and diacylglycerol (DAG)-regulated nucleotide exchange factor specifically activating Ras through the exchange of bound GDP for GTP (PubMed:15899849, PubMed:23908768, PubMed:27776107, PubMed:29155103). Activates the Erk/MAP kinase cascade (PubMed:15899849). Regulates T-cell/B-cell development, homeostasis and differentiation by coupling T-lymphocyte/B-lymphocyte antigen receptors to Ras (PubMed:10807788, PubMed:12839994, PubMed:27776107, PubMed:29155103). Regulates NK cell cytotoxicity and ITAM-dependent cytokine production by activation of Ras-mediated ERK and JNK pathways (PubMed:19933860). Functions in mast cell degranulation and cytokine secretion, regulating FcERI-evoked allergic responses. May also function in differentiation of other cell types (PubMed:12845332)","subcellular_location":"Cytoplasm, cytosol; Cell membrane; Golgi apparatus membrane; Endoplasmic reticulum membrane","url":"https://www.uniprot.org/uniprotkb/O95267/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RASGRP1","classification":"Not Classified","n_dependent_lines":6,"n_total_lines":1208,"dependency_fraction":0.004966887417218543},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CEP164","stoichiometry":0.2},{"gene":"HSPA4L","stoichiometry":0.2},{"gene":"RAB3D","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/RASGRP1","total_profiled":1310},"omim":[{"mim_id":"618534","title":"IMMUNODEFICIENCY 64 WITH LYMPHOPROLIFERATION; IMD64","url":"https://www.omim.org/entry/618534"},{"mim_id":"614581","title":"MONOCYTE-TO-MACROPHAGE DIFFERENTIATION-ASSOCIATED PROTEIN 2; MMD2","url":"https://www.omim.org/entry/614581"},{"mim_id":"612840","title":"LEUKOCYTE ADHESION DEFICIENCY, TYPE III; LAD3","url":"https://www.omim.org/entry/612840"},{"mim_id":"607943","title":"RAS p21 PROTEIN ACTIVATOR 4; RASA4","url":"https://www.omim.org/entry/607943"},{"mim_id":"607901","title":"FERM DOMAIN-CONTAINING KINDLIN 3; FERMT3","url":"https://www.omim.org/entry/607901"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Cytosol","reliability":"Supported"},{"location":"Plasma membrane","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":23.3},{"tissue":"lymphoid tissue","ntpm":35.6},{"tissue":"retina","ntpm":16.6}],"url":"https://www.proteinatlas.org/search/RASGRP1"},"hgnc":{"alias_symbol":["CalDAG-GEFII","RASGRP"],"prev_symbol":[]},"alphafold":{"accession":"O95267","domains":[{"cath_id":"1.20.870.10","chopping":"42-184","consensus_level":"high","plddt":81.6756,"start":42,"end":184},{"cath_id":"1.10.840.10","chopping":"200-350_399-432","consensus_level":"high","plddt":90.2487,"start":200,"end":432},{"cath_id":"1.10.238.10","chopping":"462-538","consensus_level":"medium","plddt":79.204,"start":462,"end":538},{"cath_id":"3.30.60.20","chopping":"539-593","consensus_level":"medium","plddt":86.3347,"start":539,"end":593}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O95267","model_url":"https://alphafold.ebi.ac.uk/files/AF-O95267-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O95267-F1-predicted_aligned_error_v6.png","plddt_mean":71.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RASGRP1","jax_strain_url":"https://www.jax.org/strain/search?query=RASGRP1"},"sequence":{"accession":"O95267","fasta_url":"https://rest.uniprot.org/uniprotkb/O95267.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O95267/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O95267"}},"corpus_meta":[{"pmid":"9582122","id":"PMC_9582122","title":"RasGRP, a Ras guanyl nucleotide- releasing protein with calcium- and diacylglycerol-binding motifs.","date":"1998","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9582122","citation_count":565,"is_preprint":false},{"pmid":"12845332","id":"PMC_12845332","title":"Phospholipase Cgamma activates Ras on the Golgi apparatus by means of RasGRP1.","date":"2003","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/12845332","citation_count":355,"is_preprint":false},{"pmid":"11017103","id":"PMC_11017103","title":"RasGRP is essential for mouse thymocyte differentiation and TCR signaling.","date":"2000","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11017103","citation_count":349,"is_preprint":false},{"pmid":"10807788","id":"PMC_10807788","title":"RasGRP links T-cell receptor signaling to Ras.","date":"2000","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10807788","citation_count":287,"is_preprint":false},{"pmid":"9819387","id":"PMC_9819387","title":"Regulation of RasGRP via a phorbol ester-responsive C1 domain.","date":"1998","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9819387","citation_count":195,"is_preprint":false},{"pmid":"15899849","id":"PMC_15899849","title":"A diacylglycerol-protein kinase C-RasGRP1 pathway directs Ras activation upon antigen receptor stimulation of T cells.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15899849","citation_count":163,"is_preprint":false},{"pmid":"22961080","id":"PMC_22961080","title":"A genome-wide association study identifies GRK5 and RASGRP1 as type 2 diabetes loci in Chinese Hans.","date":"2012","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/22961080","citation_count":152,"is_preprint":false},{"pmid":"17283063","id":"PMC_17283063","title":"Unusual interplay of two types of Ras activators, RasGRP and SOS, establishes sensitive and robust Ras activation in lymphocytes.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17283063","citation_count":145,"is_preprint":false},{"pmid":"12433368","id":"PMC_12433368","title":"RasGRP1 transduces low-grade TCR signals which are critical for T cell development, homeostasis, and differentiation.","date":"2002","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/12433368","citation_count":129,"is_preprint":false},{"pmid":"15064353","id":"PMC_15064353","title":"Diacylglycerol-dependent binding recruits PKCtheta and RasGRP1 C1 domains to specific subcellular localizations in living T lymphocytes.","date":"2004","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/15064353","citation_count":117,"is_preprint":false},{"pmid":"16301621","id":"PMC_16301621","title":"RasGRP1 and RasGRP3 regulate B cell proliferation by facilitating B cell receptor-Ras signaling.","date":"2005","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16301621","citation_count":111,"is_preprint":false},{"pmid":"12782630","id":"PMC_12782630","title":"Exchange factors of the RasGRP family mediate Ras activation in the Golgi.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12782630","citation_count":110,"is_preprint":false},{"pmid":"27776107","id":"PMC_27776107","title":"RASGRP1 deficiency causes immunodeficiency with impaired cytoskeletal dynamics.","date":"2016","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27776107","citation_count":109,"is_preprint":false},{"pmid":"10779365","id":"PMC_10779365","title":"The guanine nucleotide exchange factor RasGRP is a high -affinity target for diacylglycerol and phorbol esters.","date":"2000","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/10779365","citation_count":102,"is_preprint":false},{"pmid":"21441934","id":"PMC_21441934","title":"STIM1, PKC-δ and RasGRP set a threshold for proapoptotic Erk signaling during B cell development.","date":"2011","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21441934","citation_count":101,"is_preprint":false},{"pmid":"21779502","id":"PMC_21779502","title":"Regulation and Function of the RasGRP Family of Ras Activators in Blood Cells.","date":"2011","source":"Genes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21779502","citation_count":94,"is_preprint":false},{"pmid":"14764585","id":"PMC_14764585","title":"Vav1 transduces T cell receptor signals to the activation of the Ras/ERK pathway via LAT, Sos, and RasGRP1.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14764585","citation_count":80,"is_preprint":false},{"pmid":"11919165","id":"PMC_11919165","title":"Expression of a catalytically inactive form of diacylglycerol kinase alpha induces sustained signaling through RasGRP.","date":"2002","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/11919165","citation_count":65,"is_preprint":false},{"pmid":"23908768","id":"PMC_23908768","title":"Structural analysis of autoinhibition in the Ras-specific exchange factor RasGRP1.","date":"2013","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/23908768","citation_count":64,"is_preprint":false},{"pmid":"29282224","id":"PMC_29282224","title":"Loss of RASGRP1 in humans impairs T-cell expansion leading to Epstein-Barr virus susceptibility.","date":"2018","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29282224","citation_count":63,"is_preprint":false},{"pmid":"26005835","id":"PMC_26005835","title":"RasGRP1 opposes proliferative EGFR-SOS1-Ras signals and restricts intestinal epithelial cell growth.","date":"2015","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/26005835","citation_count":62,"is_preprint":false},{"pmid":"17190838","id":"PMC_17190838","title":"An essential role for RasGRP1 in mast cell function and IgE-mediated allergic response.","date":"2006","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17190838","citation_count":55,"is_preprint":false},{"pmid":"12932358","id":"PMC_12932358","title":"Autoimmunity as the consequence of a spontaneous mutation in Rasgrp1.","date":"2003","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/12932358","citation_count":51,"is_preprint":false},{"pmid":"19171906","id":"PMC_19171906","title":"Dysregulation of CalDAG-GEFI and CalDAG-GEFII predicts the severity of motor side-effects induced by anti-parkinsonian therapy.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19171906","citation_count":49,"is_preprint":false},{"pmid":"15923197","id":"PMC_15923197","title":"A novel diacylglycerol-lactone shows marked selectivity in vitro among C1 domains of protein kinase C (PKC) isoforms alpha and delta as well as selectivity for RasGRP compared with PKCalpha.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15923197","citation_count":48,"is_preprint":false},{"pmid":"29155103","id":"PMC_29155103","title":"RASGRP1 mutation in autoimmune lymphoproliferative syndrome-like disease.","date":"2017","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29155103","citation_count":46,"is_preprint":false},{"pmid":"23532335","id":"PMC_23532335","title":"Dysregulated RasGRP1 responds to cytokine receptor input in T cell leukemogenesis.","date":"2013","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/23532335","citation_count":45,"is_preprint":false},{"pmid":"24744772","id":"PMC_24744772","title":"RasGRP Ras guanine nucleotide exchange factors in cancer.","date":"2013","source":"Frontiers in biology","url":"https://pubmed.ncbi.nlm.nih.gov/24744772","citation_count":45,"is_preprint":false},{"pmid":"28822832","id":"PMC_28822832","title":"Combined immunodeficiency with EBV positive B cell lymphoma and epidermodysplasia verruciformis due to a novel homozygous mutation in RASGRP1.","date":"2017","source":"Clinical immunology (Orlando, Fla.)","url":"https://pubmed.ncbi.nlm.nih.gov/28822832","citation_count":45,"is_preprint":false},{"pmid":"21957144","id":"PMC_21957144","title":"Critical roles of RasGRP1 for invariant NKT cell development.","date":"2011","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/21957144","citation_count":43,"is_preprint":false},{"pmid":"24336796","id":"PMC_24336796","title":"Rasgrp1 mutation increases naive T-cell CD44 expression and drives mTOR-dependent accumulation of Helios⁺ T cells and autoantibodies.","date":"2013","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/24336796","citation_count":43,"is_preprint":false},{"pmid":"30030704","id":"PMC_30030704","title":"Novel Mutations in RASGRP1 are Associated with Immunodeficiency, Immune Dysregulation, and EBV-Induced Lymphoma.","date":"2018","source":"Journal of clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30030704","citation_count":42,"is_preprint":false},{"pmid":"20203268","id":"PMC_20203268","title":"The transcription factor Gfi1 regulates G-CSF signaling and neutrophil development through the Ras activator RasGRP1.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/20203268","citation_count":42,"is_preprint":false},{"pmid":"20392800","id":"PMC_20392800","title":"RasGRP1 stimulation enhances ubiquitination and endocytosis of the sodium-chloride cotransporter.","date":"2010","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20392800","citation_count":41,"is_preprint":false},{"pmid":"18424717","id":"PMC_18424717","title":"Preferential development of CD4 and CD8 T regulatory cells in RasGRP1-deficient mice.","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18424717","citation_count":40,"is_preprint":false},{"pmid":"26549032","id":"PMC_26549032","title":"RasGRP1 overexpression in T-ALL increases basal nucleotide exchange on Ras rendering the Ras/PI3K/Akt pathway responsive to protumorigenic cytokines.","date":"2015","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/26549032","citation_count":39,"is_preprint":false},{"pmid":"19465406","id":"PMC_19465406","title":"Association of RASGRP1 with type 1 diabetes is revealed by combined follow-up of two genome-wide studies.","date":"2009","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19465406","citation_count":39,"is_preprint":false},{"pmid":"28952923","id":"PMC_28952923","title":"A Histidine pH sensor regulates activation of the Ras-specific guanine nucleotide exchange factor RasGRP1.","date":"2017","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/28952923","citation_count":38,"is_preprint":false},{"pmid":"14532295","id":"PMC_14532295","title":"RasGRP1 represents a novel non-protein kinase C phorbol ester signaling pathway in mouse epidermal keratinocytes.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14532295","citation_count":38,"is_preprint":false},{"pmid":"19100522","id":"PMC_19100522","title":"A proapoptotic signaling pathway involving RasGRP, Erk, and Bim in B cells.","date":"2009","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/19100522","citation_count":36,"is_preprint":false},{"pmid":"14583629","id":"PMC_14583629","title":"Diacylglycerols containing Omega 3 and Omega 6 fatty acids bind to RasGRP and modulate MAP kinase activation.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14583629","citation_count":36,"is_preprint":false},{"pmid":"18077438","id":"PMC_18077438","title":"Phorbol ester stimulation of RasGRP1 regulates the sodium-chloride cotransporter by a PKC-independent pathway.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18077438","citation_count":35,"is_preprint":false},{"pmid":"19933860","id":"PMC_19933860","title":"RasGRP1 is required for human NK cell function.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19933860","citation_count":34,"is_preprint":false},{"pmid":"17210708","id":"PMC_17210708","title":"Transgenic overexpression of RasGRP1 in mouse epidermis results in spontaneous tumors of the skin.","date":"2007","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/17210708","citation_count":34,"is_preprint":false},{"pmid":"15829980","id":"PMC_15829980","title":"Deregulated expression of RasGRP1 initiates thymic lymphomagenesis independently of T-cell receptors.","date":"2005","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15829980","citation_count":33,"is_preprint":false},{"pmid":"21482356","id":"PMC_21482356","title":"A RasGRP, C. elegans RGEF-1b, couples external stimuli to behavior by activating LET-60 (Ras) in sensory neurons.","date":"2011","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/21482356","citation_count":32,"is_preprint":false},{"pmid":"32612143","id":"PMC_32612143","title":"Nurr1 performs its anti-inflammatory function by regulating RasGRP1 expression in neuro-inflammation.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32612143","citation_count":31,"is_preprint":false},{"pmid":"11689073","id":"PMC_11689073","title":"Iridals are a novel class of ligands for phorbol ester receptors with modest selectivity for the RasGRP receptor subfamily.","date":"2001","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11689073","citation_count":31,"is_preprint":false},{"pmid":"27890930","id":"PMC_27890930","title":"Histone deacetylase inhibitors interrupt HSP90•RASGRP1 and HSP90•CRAF interactions to upregulate BIM and circumvent drug resistance in lymphoma cells.","date":"2016","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/27890930","citation_count":29,"is_preprint":false},{"pmid":"29655291","id":"PMC_29655291","title":"Sp1-regulated transcription of RasGRP1 promotes hepatocellular carcinoma (HCC) proliferation.","date":"2018","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/29655291","citation_count":28,"is_preprint":false},{"pmid":"17675473","id":"PMC_17675473","title":"Chronic immunodeficiency in mice lacking RasGRP1 results in CD4 T cell immune activation and exhaustion.","date":"2007","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17675473","citation_count":28,"is_preprint":false},{"pmid":"11503142","id":"PMC_11503142","title":"Guanine nucleotide exchange factors CalDAG-GEFI and CalDAG-GEFII are colocalized in striatal projection neurons.","date":"2001","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/11503142","citation_count":28,"is_preprint":false},{"pmid":"27902448","id":"PMC_27902448","title":"RasGRP1 promotes amphetamine-induced motor behavior through a Rhes interaction network (\"Rhesactome\") in the striatum.","date":"2016","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/27902448","citation_count":28,"is_preprint":false},{"pmid":"28652304","id":"PMC_28652304","title":"Thymic progenitors of TCRαβ+ CD8αα intestinal intraepithelial lymphocytes require RasGRP1 for development.","date":"2017","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28652304","citation_count":27,"is_preprint":false},{"pmid":"22116551","id":"PMC_22116551","title":"Aberrant expression of RasGRP1 cooperates with gain-of-function NOTCH1 mutations in T-cell leukemogenesis.","date":"2011","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/22116551","citation_count":26,"is_preprint":false},{"pmid":"32426479","id":"PMC_32426479","title":"RasGRP1 is a causal factor in the development of l-DOPA-induced dyskinesia in Parkinson's disease.","date":"2020","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/32426479","citation_count":26,"is_preprint":false},{"pmid":"32459053","id":"PMC_32459053","title":"BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T-cell lymphoblastic lymphoma.","date":"2020","source":"Cancer communications (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/32459053","citation_count":25,"is_preprint":false},{"pmid":"29905030","id":"PMC_29905030","title":"Decreased Expression of Serine/Arginine-Rich Splicing Factor 1 in T Cells From Patients With Active Systemic Lupus Erythematosus Accounts for Reduced Expression of RasGRP1 and DNA Methyltransferase 1.","date":"2018","source":"Arthritis & rheumatology (Hoboken, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/29905030","citation_count":25,"is_preprint":false},{"pmid":"12538669","id":"PMC_12538669","title":"Transgenic expression of RasGRP1 induces the maturation of double-negative thymocytes and enhances the production of CD8 single-positive thymocytes.","date":"2003","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12538669","citation_count":24,"is_preprint":false},{"pmid":"22623331","id":"PMC_22623331","title":"Differential requirement of RasGRP1 for γδ T cell development and activation.","date":"2012","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/22623331","citation_count":23,"is_preprint":false},{"pmid":"14970203","id":"PMC_14970203","title":"RasGRP1 sensitizes an immature B cell line to antigen receptor-induced apoptosis.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14970203","citation_count":23,"is_preprint":false},{"pmid":"17658605","id":"PMC_17658605","title":"SKAP55 modulates T cell antigen receptor-induced activation of the Ras-Erk-AP1 pathway by binding RasGRP1.","date":"2007","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17658605","citation_count":23,"is_preprint":false},{"pmid":"36385095","id":"PMC_36385095","title":"RasGRP1 promotes the acute inflammatory response and restricts inflammation-associated cancer cell growth.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36385095","citation_count":22,"is_preprint":false},{"pmid":"15588099","id":"PMC_15588099","title":"Synthetic bryostatin analogues activate the RasGRP1 signaling pathway.","date":"2004","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15588099","citation_count":22,"is_preprint":false},{"pmid":"22719950","id":"PMC_22719950","title":"Regulation of RasGRP1 function in T cell development and activation by its unique tail domain.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22719950","citation_count":22,"is_preprint":false},{"pmid":"31237864","id":"PMC_31237864","title":"RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer.","date":"2019","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/31237864","citation_count":22,"is_preprint":false},{"pmid":"17567957","id":"PMC_17567957","title":"Regulation of RasGRP1 by B cell antigen receptor requires cooperativity between three domains controlling translocation to the plasma membrane.","date":"2007","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/17567957","citation_count":21,"is_preprint":false},{"pmid":"17974959","id":"PMC_17974959","title":"RasGRP1 overexpression in the epidermis of transgenic mice contributes to tumor progression during multistage skin carcinogenesis.","date":"2007","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/17974959","citation_count":21,"is_preprint":false},{"pmid":"11831896","id":"PMC_11831896","title":"Structural basis of RasGRP binding to high-affinity PKC ligands.","date":"2002","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11831896","citation_count":20,"is_preprint":false},{"pmid":"21976405","id":"PMC_21976405","title":"Constitutive abnormal expression of RasGRP-1 isoforms and low expression of PARP-1 in patients with systemic lupus erythematosus.","date":"2011","source":"Lupus","url":"https://pubmed.ncbi.nlm.nih.gov/21976405","citation_count":20,"is_preprint":false},{"pmid":"20007535","id":"PMC_20007535","title":"RasGRP1 regulates antigen-induced developmental programming by naive CD8 T cells.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/20007535","citation_count":20,"is_preprint":false},{"pmid":"19168098","id":"PMC_19168098","title":"Membrane localization of RasGRP1 is controlled by an EF-hand, and by the GEF domain.","date":"2009","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/19168098","citation_count":19,"is_preprint":false},{"pmid":"19497993","id":"PMC_19497993","title":"RasGRP1 transgenic mice develop cutaneous squamous cell carcinomas in response to skin wounding: potential role of granulocyte colony-stimulating factor.","date":"2009","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/19497993","citation_count":19,"is_preprint":false},{"pmid":"26714738","id":"PMC_26714738","title":"Dysregulation of RasGRP1 in rheumatoid arthritis and modulation of RasGRP3 as a biomarker of TNFα inhibitors.","date":"2015","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/26714738","citation_count":18,"is_preprint":false},{"pmid":"24464785","id":"PMC_24464785","title":"Targeted deletion of RasGRP1 impairs skin tumorigenesis.","date":"2014","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/24464785","citation_count":18,"is_preprint":false},{"pmid":"27804980","id":"PMC_27804980","title":"Novel identified associations of RGS1 and RASGRP1 variants in IgA Nephropathy.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27804980","citation_count":18,"is_preprint":false},{"pmid":"16849453","id":"PMC_16849453","title":"RasGRP1 transmits prodifferentiation TCR signaling that is crucial for CD4 T cell development.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16849453","citation_count":18,"is_preprint":false},{"pmid":"21285350","id":"PMC_21285350","title":"Phosphoinositide 3-kinase regulates plasma membrane targeting of the Ras-specific exchange factor RasGRP1.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21285350","citation_count":18,"is_preprint":false},{"pmid":"33065764","id":"PMC_33065764","title":"Dysregulated RASGRP1 expression through RUNX1 mediated transcription promotes autoimmunity.","date":"2020","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33065764","citation_count":17,"is_preprint":false},{"pmid":"31164884","id":"PMC_31164884","title":"Mechanistic Characterization of RASGRP1 Variants Identifies an hnRNP-K-Regulated Transcriptional Enhancer Contributing to SLE Susceptibility.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31164884","citation_count":17,"is_preprint":false},{"pmid":"32830401","id":"PMC_32830401","title":"Novel tumour suppressor roles for GZMA and RASGRP1 in Theileria annulata-transformed macrophages and human B lymphoma cells.","date":"2020","source":"Cellular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/32830401","citation_count":16,"is_preprint":false},{"pmid":"16546974","id":"PMC_16546974","title":"Differential effects of bryostatin 1 and 12-O-tetradecanoylphorbol-13-acetate on the regulation and activation of RasGRP1 in mouse epidermal keratinocytes.","date":"2006","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/16546974","citation_count":16,"is_preprint":false},{"pmid":"21856938","id":"PMC_21856938","title":"G alpha i2 and ZAP-70 mediate RasGRP1 membrane localization and activation of SDF-1-induced T cell functions.","date":"2011","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/21856938","citation_count":16,"is_preprint":false},{"pmid":"24794745","id":"PMC_24794745","title":"Synthesis, biological, and biophysical studies of DAG-indololactones designed as selective activators of RasGRP.","date":"2014","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24794745","citation_count":15,"is_preprint":false},{"pmid":"23997211","id":"PMC_23997211","title":"Multiple checkpoint breach of B cell tolerance in Rasgrp1-deficient mice.","date":"2013","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/23997211","citation_count":15,"is_preprint":false},{"pmid":"18320039","id":"PMC_18320039","title":"Adaptor SKAP-55 binds p21 activating exchange factor RasGRP1 and negatively regulates the p21-ERK pathway in T-cells.","date":"2008","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/18320039","citation_count":15,"is_preprint":false},{"pmid":"23209318","id":"PMC_23209318","title":"A phospholipase C-γ1-independent, RasGRP1-ERK-dependent pathway drives lymphoproliferative disease in linker for activation of T cells-Y136F mutant mice.","date":"2012","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/23209318","citation_count":15,"is_preprint":false},{"pmid":"31691004","id":"PMC_31691004","title":"High-throughput transcriptome analysis reveals that the loss of Pten activates a novel NKX6-1/RASGRP1 regulatory module to rescue microphthalmia caused by Fgfr2-deficient lenses.","date":"2019","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31691004","citation_count":15,"is_preprint":false},{"pmid":"22005268","id":"PMC_22005268","title":"Parathyroid hormone (PTH) regulates the sodium chloride cotransporter via Ras guanyl releasing protein 1 (Ras-GRP1) and extracellular signal-regulated kinase (ERK)1/2 mitogen-activated protein kinase (MAPK) pathway.","date":"2011","source":"Translational research : the journal of laboratory and clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22005268","citation_count":15,"is_preprint":false},{"pmid":"26851222","id":"PMC_26851222","title":"RasGRP1 Is an Essential Signaling Molecule for Development of B1a Cells with Autoantigen Receptors.","date":"2016","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/26851222","citation_count":15,"is_preprint":false},{"pmid":"38759314","id":"PMC_38759314","title":"Targeting macrophagic RasGRP1 with catechin hydrate ameliorates sepsis-induced multiorgan dysfunction.","date":"2024","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38759314","citation_count":14,"is_preprint":false},{"pmid":"11279364","id":"PMC_11279364","title":"Distribution of ras guanyl releasing protein (RasGRP) mRNA in the adult rat central nervous system.","date":"2000","source":"Journal of neurocytology","url":"https://pubmed.ncbi.nlm.nih.gov/11279364","citation_count":14,"is_preprint":false},{"pmid":"23308188","id":"PMC_23308188","title":"RasGRP1, but not RasGRP3, is required for efficient thymic β-selection and ERK activation downstream of CXCR4.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23308188","citation_count":13,"is_preprint":false},{"pmid":"27465532","id":"PMC_27465532","title":"RasGRP1 and RasGRP3 Are Required for Efficient Generation of Early Thymic Progenitors.","date":"2016","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/27465532","citation_count":12,"is_preprint":false},{"pmid":"20308057","id":"PMC_20308057","title":"RasGRP1 is essential for ras activation by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate in epidermal keratinocytes.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20308057","citation_count":12,"is_preprint":false},{"pmid":"31120617","id":"PMC_31120617","title":"RasGRP1 is a target for VEGF to induce angiogenesis and involved in the endothelial-protective effects of metformin under high glucose in HUVECs.","date":"2019","source":"IUBMB life","url":"https://pubmed.ncbi.nlm.nih.gov/31120617","citation_count":11,"is_preprint":false},{"pmid":"28392275","id":"PMC_28392275","title":"Exploring the influence of indololactone structure on selectivity for binding to the C1 domains of PKCα, PKCε, and RasGRP.","date":"2017","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28392275","citation_count":10,"is_preprint":false},{"pmid":"33512434","id":"PMC_33512434","title":"Nras Q61R/+ and Kras-/- cooperate to downregulate Rasgrp1 and promote lympho-myeloid leukemia in early T-cell precursors.","date":"2021","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/33512434","citation_count":10,"is_preprint":false},{"pmid":"10087292","id":"PMC_10087292","title":"RasGRP, a Ras activator: mouse and human cDNA sequences and chromosomal positions.","date":"1999","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/10087292","citation_count":9,"is_preprint":false},{"pmid":"27279372","id":"PMC_27279372","title":"Autoantibody-Mediated Pulmonary Alveolar Proteinosis in Rasgrp1-Deficient Mice.","date":"2016","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/27279372","citation_count":9,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51490,"output_tokens":9704,"usd":0.150015},"stage2":{"model":"claude-opus-4-6","input_tokens":13629,"output_tokens":4299,"usd":0.26343},"total_usd":0.413445,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"RasGRP1 was characterized as a guanine nucleotide exchange factor (GEF) for Ras with a catalytic domain, an atypical pair of EF hands that bind calcium, and a diacylglycerol (DAG)-binding C1 domain. DAG/phorbol ester binding recruits RasGRP1 to the membrane fraction, and deletion of the DAG-binding domain abolished sustained Ras-ERK signaling and membrane partitioning.\",\n      \"method\": \"cDNA characterization, domain deletion mutagenesis, cellular fractionation, Ras-ERK signaling assays, fibroblast transformation assay\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original biochemical characterization with domain mutagenesis and multiple functional readouts, foundational paper with 565 citations\",\n      \"pmids\": [\"9582122\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The C1 domain of RasGRP1 (or membrane-localizing prenylation signal replacing it) is required for transforming activity and MAP kinase activation; a point mutation in the catalytic domain preventing Ras interaction abolishes transformation; the C1 domain mediates translocation to cell membranes in response to phorbol ester or serum stimulation.\",\n      \"method\": \"Point mutagenesis, domain deletion, NIH 3T3 transformation assay, MAP kinase activation assay, membrane translocation imaging\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis of catalytic and C1 domains with multiple orthogonal functional assays\",\n      \"pmids\": [\"9819387\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"RasGRP1 links T cell receptor (TCR) signaling to Ras activation downstream of PLCγ1 and DAG. Antibodies against RasGRP1 inhibited Ras-guanyl nucleotide exchange activity in membranes from TCR-stimulated Jurkat cells; a PLCγ1 inhibitor reduced Ras activation; overexpression of RasGRP1 enhanced TCR-Ras-ERK signaling and IL-2 secretion.\",\n      \"method\": \"Inhibitory antibody experiments, PLCγ1 inhibitor treatment, overexpression in T cells, Ras activation assays, IL-2 secretion assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (antibody inhibition, pharmacological inhibition, overexpression) in T cells\",\n      \"pmids\": [\"10807788\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"RasGRP1 is essential for thymocyte differentiation: RasGRP1-null mice have normal immature thymocyte numbers but a marked deficiency of mature single-positive thymocytes, and mutant thymocytes completely lack Ras signaling and proliferation in response to DAG analogs or TCR stimulation.\",\n      \"method\": \"RasGRP1 knockout mouse model, thymocyte phenotyping (flow cytometry), Ras signaling and proliferation assays\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with specific cellular phenotype, replicated by multiple labs\",\n      \"pmids\": [\"11017103\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"RasGRP1's C1 domain binds phorbol esters and DAG with high affinity (Kd ~0.58 nM for [3H]PDBu), similar to PKC; calcium does not affect phorbol ester binding; acidic phospholipid requirements differ from PKC.\",\n      \"method\": \"Radioligand binding assay ([3H]PDBu), competition binding with phorbol ester analogs and bryostatin 1\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro binding assay with rigorous pharmacological characterization\",\n      \"pmids\": [\"10779365\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"In response to Src-dependent activation of PLCγ1, RasGRP1 translocates to the Golgi apparatus where it activates Ras. Ca2+ positively regulates Ras on the Golgi through RasGRP1 while negatively regulating Ras on the plasma membrane via CAPRI. Ras activation after TCR stimulation in Jurkat cells (rich in RasGRP1) is limited to the Golgi.\",\n      \"method\": \"Live-cell imaging of RasGRP1 translocation, Ras activation assays at specific compartments, Src inhibition, Ca2+ manipulation, Jurkat T cell TCR stimulation\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including compartment-specific Ras assays and live imaging, replicated context\",\n      \"pmids\": [\"12845332\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Members of the RasGRP family (including RasGRP1) are the only Ras activators that localize to the Golgi and can induce GTP loading of Ras at the Golgi; Ras activation at the plasma membrane can be achieved by most Ras activators but Golgi-specific Ras activation requires RasGRPs.\",\n      \"method\": \"Subcellular distribution assays, compartment-specific Ras activation assays in cells expressing various GEFs\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic comparison of multiple GEFs for compartment-specific Ras activation\",\n      \"pmids\": [\"12782630\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"DGKα (diacylglycerol kinase alpha) acts as a negative modulator of RasGRP1 signaling by metabolizing DAG; expression of catalytically inactive DGKα leads to sustained DAG accumulation, sustained RasGRP1 membrane translocation, and sustained MAPK activation downstream of TCR.\",\n      \"method\": \"Expression of kinase-dead DGKα, DAG measurement, RasGRP1 membrane translocation assay, MAPK activation assay in T cells\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — catalytic mutant and biochemical assays establishing DAG as the key regulator of RasGRP1 membrane recruitment\",\n      \"pmids\": [\"11919165\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The C1 domains of RasGRP1 and PKCθ show specific localization within T cells and distinct responses to pharmacological stimulation and TCR triggering, reflecting their binding to different DAG pools at distinct subcellular locations (plasma membrane vs. internal membranes); overexpression of C1 domains can attenuate DAG-dependent Ras activation signals from specific compartments.\",\n      \"method\": \"Live-cell imaging of GFP-tagged C1 domains in Jurkat T cells, pharmacological stimulation, TCR triggering, Ras activation assays\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — live imaging with functional consequence (Ras activation attenuation) in living T cells\",\n      \"pmids\": [\"15064353\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"RasGRP1 is required for optimal antigen receptor-triggered Ras-ERK activation in T cells via its DAG-binding domain; phosphorylation of threonine 184 in RasGRP1 (driven by novel PKC kinases) correlates with ERK activation; active PKCθ requires RasGRP1 sufficiency to trigger downstream events, defining a DAG-PKC-RasGRP1-Ras-ERK pathway distinct from SOS-mediated activation.\",\n      \"method\": \"RasGRP1-deficient Jurkat T-cell clone, RNAi knockdown, domain mutagenesis (DAG-binding domain), phosphorylation analysis, ERK activation assays, genetic epistasis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches including genetic KO clone, RNAi, mutagenesis, and phosphorylation mapping\",\n      \"pmids\": [\"15899849\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"RasGRP1 orchestrates Ras signaling in lymphocytes in two ways: (i) by directly activating Ras, and (ii) by facilitating priming of SOS with Ras-GTP that binds SOS's allosteric pocket, creating a positive RasGTP-SOS feedback loop that functions as a rheostat. Without RasGRP1, initiation of this SOS feedback loop is impaired, explaining RasGRP1 dominance over SOS.\",\n      \"method\": \"T- and B-cell line genetic manipulation, SOS allosteric mutants, RasGTP measurement, active Ras-like molecule (RasV12C40) rescue experiment\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic epistasis with allosteric mutants and rescue experiments establishing the RasGRP1-SOS feedback loop\",\n      \"pmids\": [\"17283063\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Vav1 transduces TCR signals to Ras-ERK by controlling membrane recruitment of RasGRP1 (via PLCγ1 activation) and recruitment of Sos1/2 to LAT; Vav1 is required for TCR-induced LAT phosphorylation, which is a key upstream event for PLCγ1 activation and subsequent RasGRP1 membrane recruitment.\",\n      \"method\": \"Genetic KO of Vav1, epistasis analysis, membrane recruitment assays, LAT phosphorylation analysis in double-positive thymocytes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with mechanistic pathway placement showing Vav1→LAT→PLCγ1→RasGRP1\",\n      \"pmids\": [\"14764585\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"RasGRP1 regulation by B cell antigen receptor (BCR) requires cooperativity between three domains: the C1 domain (binds DAG from BCR-coupled PLCγ2), the Plasma membrane Targeter (PT) domain (sufficient and essential for plasma membrane targeting), and the Suppressor of PT (SuPT) domain (attenuates PT activity, preventing constitutive plasma membrane localization). DAG binding by C1 counteracts SuPT, enabling translocation.\",\n      \"method\": \"Domain deletion and mutation analysis, BCR ligation, live-cell imaging of RasGRP1 translocation, subcellular fractionation in B cell lines\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic domain dissection with multiple deletion mutants and live imaging\",\n      \"pmids\": [\"17567957\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The EF1 hand of RasGRP1 is required for receptor-induced translocation to the plasma membrane in B cell lines by counteracting the SuPT domain; EF1-mediated translocation does not involve antigen receptor-induced Ca2+ flux but is regulated by alternative splicing. The Ras-binding site in the catalytic GEF domain is required for both PT-mediated plasma membrane targeting and C1-mediated endomembrane localization, suggesting positive feedback between the GEF domain and membrane-binding domains.\",\n      \"method\": \"EF1 mutagenesis, alternative splicing analysis, Ca2+ chelation, subcellular localization assays in B cell lines, GEF domain mutagenesis\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic mutagenesis of multiple regulatory elements with mechanistic follow-up\",\n      \"pmids\": [\"19168098\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Phosphoinositide 3-kinase (PI3K) signaling generates phosphoinositides that are directly detected by a basic/hydrophobic cluster within the plasma membrane-targeting domain of RasGRP1, providing a novel mechanism for plasma membrane targeting that cooperates with DAG detection by the C1 domain; this couples PI3K and RAS signaling.\",\n      \"method\": \"Phospholipid vesicle binding assay, PI3K inhibition, BCR ligation, point mutagenesis of basic/hydrophobic cluster, subcellular localization assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro phospholipid binding assay plus mutagenesis and cellular localization experiments\",\n      \"pmids\": [\"21285350\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"A Ca2+-driven, PKCδ- and RasGRP1-dependent pathway activates ERK in a proapoptotic manner during B cell development; this pathway is biochemically distinct from DAG-driven ERK activation and depends on STIM1 concentration controlling Ca2+ entry magnitude.\",\n      \"method\": \"PKCδ knockout mice, genetic epistasis, Ca2+ flux manipulation, STIM1 overexpression, ERK activation assays in B cells\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO + epistasis + multiple orthogonal methods establishing a Ca2+-PKCδ-RasGRP1-ERK proapoptotic pathway\",\n      \"pmids\": [\"21441934\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Crystal structure of an autoinhibited fragment of RasGRP1 revealed that the Ras-binding site is blocked by an interdomain linker and the membrane-interaction surface is hidden within a dimerization interface stabilized by the C-terminal oligomerization domain. NMR data showed Ca2+ binding to the regulatory module generates conformational changes incompatible with the inactive assembly, establishing a structural basis for activation by Ca2+ and membrane-localization signals.\",\n      \"method\": \"X-ray crystallography, NMR spectroscopy, functional domain mutagenesis\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure plus NMR with mechanistic validation, strong structural evidence\",\n      \"pmids\": [\"23908768\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Human RASGRP1 deficiency causes immunodeficiency with impaired ERK phosphorylation in T and B cells (rescued by wild-type RASGRP1 expression), defective proliferation, activation and motility; NK cell cytotoxicity was impaired due to defective granule convergence and actin accumulation. Interaction proteomics identified dynein light chain DYNLL1 as a RASGRP1-interacting protein linking it to cytoskeletal dynamics; RASGRP1-deficient cells showed decreased RhoA GTPase activation.\",\n      \"method\": \"Homozygosity mapping, exome sequencing, RASGRP1 rescue by wild-type expression, interaction proteomics, RhoA activation assay, NK cell cytotoxicity assay, live-cell imaging\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — human patient genetics with functional rescue, interaction proteomics, and multiple cellular phenotype assays\",\n      \"pmids\": [\"27776107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"His 212 in RasGRP1 acts as a pH sensor that alters signaling activity and plasma membrane recruitment by modulating the balance between inactive and active conformations; structural comparison of autoinhibited RasGRP1 with active RasGRP4:H-Ras and RasGRP2:Rap1b complexes revealed that the transition from inactive to active involves rearrangement of an inter-domain linker at His 212, which displaces inhibitory inter-domain interactions.\",\n      \"method\": \"SNP variant analysis, RasGRP1 crystal structure comparison, plasma membrane recruitment assays, signaling activity assays with His212 mutants\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structural analysis combined with functional validation of pH-sensitive conformational switch\",\n      \"pmids\": [\"28952923\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"SKAP55 co-immunoprecipitates with RasGRP1 via its C-terminus in a tyrosine phosphorylation-enhanced manner; SKAP55 modulates TCR signaling to Ras-ERK-AP1 by binding RasGRP1, and loss of this binding abolishes SKAP55-mediated inhibition of ERK and ELK activation.\",\n      \"method\": \"Co-immunoprecipitation, RNAi knockdown, overexpression, reporter gene assays in primary human T cells and Jurkat cells\",\n      \"journal\": \"Molecular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP plus functional follow-up, single lab\",\n      \"pmids\": [\"17658605\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"SDF-1 (CXCL12) stimulation induces formation of a molecular signaling complex containing RasGRP1, Gαi2, and ZAP-70, causing RasGRP1 to localize to the plasma membrane (activating K-Ras) and Golgi (activating N-Ras); SDF-1-dependent RasGRP1 localization does not require its DAG-binding domain (unlike antigen receptor stimulation) but requires TCR expression, Gi proteins, and ZAP-70.\",\n      \"method\": \"RasGRP1 knockdown (RNAi), co-immunoprecipitation, subcellular localization assays, compartment-specific Ras activation assays, Gi inhibition (pertussis toxin), ZAP-70 inhibition in human T cells\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including co-IP, compartment-specific Ras assays, and targeted inhibition\",\n      \"pmids\": [\"21856938\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"RasGRP1 stimulation by phorbol ester (TPA) regulates the sodium-chloride cotransporter (NCC) surface expression through a PKC-independent, RasGRP1-ERK pathway: gene silencing of RasGRP1 prevented PE-mediated suppression of NCC activity, H-Ras activation, and ERK1/2 activation.\",\n      \"method\": \"RasGRP1 gene silencing (siRNA), thiazide-sensitive 22Na+ uptake assay, biotinylation assay, PKC inhibitors, MAPK inhibitors, H-Ras activation assay in mDCT cells\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic silencing with pharmacological controls and multiple functional readouts\",\n      \"pmids\": [\"18077438\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"RasGRP1 stimulation enhances ubiquitination and dynamin-dependent endocytosis of NCC; MEK1/2 inhibitors and RasGRP1 gene silencing blocked NCC ubiquitination, and inhibition of ubiquitination prevented PE-mediated decrease in NCC surface expression and activity.\",\n      \"method\": \"Biotinylation/internalization assays, dominant-negative dynamin construct, NCC immunoprecipitation/ubiquitin immunoblotting, RasGRP1 siRNA, radiotracer uptake assay\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple complementary assays (dominant negative, siRNA, biochemical) establishing mechanism\",\n      \"pmids\": [\"20392800\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The transcription factor Gfi1 promotes RasGRP1 expression and RasGRP1 is required for G-CSF-induced Ras/MEK/ERK signaling and neutrophil differentiation; Gfi1-null myeloid cells have reduced RasGRP1 protein and are selectively defective at G-CSF-induced ERK1/2 activation; expression of RasGRP1 in Gfi1-deficient cells rescues ERK activation and neutrophil maturation.\",\n      \"method\": \"Gfi1 knockout mice, RasGRP1 mRNA/protein quantification, Gfi1 transduction in myeloid cells, G-CSF stimulation assays, RasGRP1 re-expression rescue experiment\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO plus rescue experiment establishing Gfi1→RasGRP1→G-CSF-ERK axis\",\n      \"pmids\": [\"20203268\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"RasGRP1 plays an essential role in FcεRI-mediated PI3K activation in mast cells; RasGRP1-deficient mice failed to mount anaphylactic reactions; RasGRP1-/- mast cells had reduced degranulation, cytokine production, PI3K/Akt activation, and impaired granule translocation, microtubule formation, and RhoA activation; constitutively active N-Ras rescued degranulation and Akt activation.\",\n      \"method\": \"RasGRP1 knockout mice, passive systemic anaphylaxis assay, mast cell degranulation assay, PI3K/Akt activation assays, rescue with constitutively active N-Ras, RhoA activation assay\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with multiple phenotypic readouts and N-Ras rescue\",\n      \"pmids\": [\"17190838\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"In B cells, DAG analogue-stimulated RasGRP-Ras-Raf-MEK-ERK signaling leads to phosphorylation of proapoptotic BH3-only protein Bim by ERK; in vitro, Bim is phosphorylated by ERK on sites associated with increased apoptotic activity. Apoptosis in Toledo B-NHL cells can be suppressed by Bim downregulation or Bcl-2 overexpression.\",\n      \"method\": \"Biochemical signaling assays, in vitro ERK kinase assay with Bim substrate, Bim siRNA, Bcl-2 overexpression, Bak-Bax complex assay, mitochondrial membrane permeability assay\",\n      \"journal\": \"Experimental hematology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay plus cellular genetic manipulation establishing RasGRP-ERK-Bim apoptotic pathway\",\n      \"pmids\": [\"19100522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The unique C-terminal tail domain (~200 residues) of RasGRP1 is required for its membrane trafficking in response to TCR stimulation; tail-deleted RasGRP1 cannot traffic to the cell membrane following stimulation and cannot activate ERK; knock-in mice lacking the tail domain show aberrant thymic selection and CD4+ T cell expansion with autoantibody production.\",\n      \"method\": \"Knock-in mouse with tail domain deletion, thymocyte phenotyping, ERK activation assays, membrane localization assays after TCR stimulation\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — knock-in mouse model with mechanistic demonstration of impaired membrane trafficking\",\n      \"pmids\": [\"22719950\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"HDAC inhibitors cause acetylation of HSP90, releasing and degrading the HSP90 client proteins RASGRP1 and CRAF, leading to downregulation of MAPK pathway signaling and upregulation of pro-apoptotic BIM; RASGRP1 siRNA mimics HDAC inhibitor pro-apoptotic effects; RASGRP1 is identified as a novel HSP90 client protein.\",\n      \"method\": \"HSP90 co-immunoprecipitation, RASGRP1 siRNA, constitutively active MEK1 overexpression, BIM siRNA, in vitro and in vivo lymphoma cell assays\",\n      \"journal\": \"Leukemia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP establishing HSP90-RASGRP1 interaction plus multiple genetic perturbations defining pathway\",\n      \"pmids\": [\"27890930\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"RasGRP1 and SOS1 lie downstream of EGFR but act in functional opposition in intestinal epithelial cells; RasGRP1 creates a negative feedback loop limiting proliferative EGFR-SOS1-Ras signals; genetic Rasgrp1 depletion in mice with KRas activating mutation or Apc mutation exacerbates Ras-ERK signaling and cell proliferation.\",\n      \"method\": \"RasGRP1 knockout mice, KRas and Apc mutant mouse crosses, Ras-ERK signaling assays, cell proliferation assays in intestinal crypts\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in multiple mouse models establishing RasGRP1 as a negative feedback regulator of EGFR-SOS1-Ras\",\n      \"pmids\": [\"26005835\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Overexpression of RasGRP1 in T-ALL results in constitutively high GTP-loading rate of Ras (increased flux through RasGTP/GDP cycle) rather than static RasGTP accumulation as in KRAS(G12D); IL-2/7/9 stimulation activates Erk and Akt downstream of Ras in RasGRP1-overexpressing T-ALL relying on baseline DAG levels (not acute PLCγ activation), and IL-2/7/9 likely decrease RasGAP activity.\",\n      \"method\": \"Three distinct Ras GTP/GDP cycle assays, PLCγ inhibition, IL-2/7/9 stimulation assays, comparison with KRAS(G12D) T-ALL cells\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — three orthogonal assays measuring different aspects of Ras cycle with mechanistic comparison to KRAS oncogene\",\n      \"pmids\": [\"26549032\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"RasGRP1 promotes amphetamine-induced motor behavior through interaction with Rhes in the striatum; RasGRP1 stabilizes Rhes and increases its synaptic accumulation; depletion of RasGRP1 attenuates the enhanced locomotor response to amphetamine in partially Rhes-deficient mice; RasGRP1 affects the composition of the amphetamine-induced Rhes interactome.\",\n      \"method\": \"RasGRP1/Rhes knockout mouse crosses, locomotor behavior assay, proteomic analysis of striatal lysates (Rhesactome), synaptic fractionation\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in mice plus proteomics establishing RasGRP1-Rhes interaction and functional consequence\",\n      \"pmids\": [\"27902448\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"RasGRP1 is a causal factor in L-DOPA-induced dyskinesia (LID); L-DOPA rapidly up-regulates RasGRP1 in striatum of mouse and macaque PD models; RasGRP1 knockout dramatically diminishes LID without interfering with L-DOPA therapeutic effects; RasGRP1 acts as a GEF for Rheb (activator of mTOR) in addition to Ras, promoting L-DOPA-induced ERK and mTOR signaling in striatum.\",\n      \"method\": \"RasGRP1 knockout mice, macaque PD model, L-DOPA-induced dyskinesia scoring, ERK and mTOR signaling assays, high-resolution tandem mass spectrometry for downstream targets\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO in two animal models with mechanistic identification of Rheb as substrate\",\n      \"pmids\": [\"32426479\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SRSF1 directly binds exon 11 of RASGRP1 mRNA (via oligonucleotide-protein pulldown assay) and controls its alternative splicing; silencing SRSF1 in human T cells increases alternatively spliced (exon 11-skipping) RasGRP1 isoforms and decreases RasGRP1 protein; SRSF1 overexpression in SLE T cells recovers RasGRP1 expression, which in turn induces DNMT1/IL-2 expression.\",\n      \"method\": \"Oligonucleotide-protein pulldown assay, SRSF1 siRNA, SRSF1 overexpression, qPCR and Western blot for RasGRP1 isoforms in human T cells\",\n      \"journal\": \"Arthritis & rheumatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct RNA-binding pulldown assay plus functional genetic manipulation establishing SRSF1→RasGRP1 splicing regulation\",\n      \"pmids\": [\"29905030\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"In LAT-Y136F mutant mice where PLCγ1 binding to LAT is lost, RasGRP1 (not Sos1 or Sos2) is the major Ras GEF responsible for ERK activation and the lymphoproliferative phenotype, operating through a PLCγ1-independent pathway requiring Lck/Fyn, PKCθ, and RasGRP1 downstream of a Zap70-independent LAT pathway.\",\n      \"method\": \"Genetic analysis in LAT-Y136F mice, crosses with RasGRP1 KO, Sos1/Sos2 KO mice; kinase inhibitor experiments; ERK activation assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis across multiple KO mouse models identifying RasGRP1 as the dominant GEF in this context\",\n      \"pmids\": [\"23209318\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The transcription factor RUNX1 (with CBFB) directly regulates RASGRP1 transcription through an intronic enhancer; CRISPR-Cas9 disruption of this enhancer reduces RasGRP1 expression and RUNX1/CBFB binding; hnRNP-K binds to the SLE risk allele of rs11631591 in this enhancer in an allele-dependent manner and modulates RASGRP1 expression in T cells.\",\n      \"method\": \"CRISPR-Cas9 enhancer disruption, EMSA, mass spectrometry, ChIP-qPCR, luciferase reporter assays, hnRNP-K inhibition in Jurkat and primary T cells\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — CRISPR disruption plus multiple orthogonal methods (EMSA, MS, ChIP) establishing enhancer mechanism\",\n      \"pmids\": [\"31164884\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"RUNX1 transcriptionally regulates RASGRP1; diminished Rasgrp1 expression causes defective T lymphocyte selection and inflammatory disease whose severity inversely correlates with Rasgrp1 levels; H3K27 acetylation profiling identified a RASGRP1 enhancer harboring autoimmunity-associated SNPs with RUNX1/CBFB binding.\",\n      \"method\": \"Mouse models with graded Rasgrp1 expression, H3K27 acetylation ChIP, RUNX1 expression analysis in patient T cells, CRISPR disruption\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP, patient studies, and mouse genetic models establishing RUNX1-RASGRP1 transcriptional circuit\",\n      \"pmids\": [\"33065764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"RasGRP1 elevates apoptosis of immature B cells (WEHI-231) upon BCR ligation through down-regulation of NF-κB and Bcl-xL in a manner independent of ERK1/2; a dominant negative RasGRP1 mutant suppresses BCR-induced apoptosis.\",\n      \"method\": \"RasGRP1 overexpression, dominant negative RasGRP1 mutant, BCR ligation, NF-κB reporter, Bcl-xL immunoblot, apoptosis assay, NF-κB inhibition\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain- and loss-of-function with identification of downstream effectors (NF-κB, Bcl-xL)\",\n      \"pmids\": [\"14970203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PTH suppresses NCC function via a PLC/RasGRP1/ERK pathway: PLC inhibition prevented PTH effect; gene silencing of RasGRP1 prevented PTH-mediated NCC activity suppression, H-Ras activation, and ERK1/2 activation; PKC and PKA inhibitors had no effect, establishing a PKC-independent pathway.\",\n      \"method\": \"RasGRP1 gene silencing, PTH stimulation, PLC inhibitor, PKC/PKA inhibitors, MAPK inhibitor, 22Na+ uptake assay, H-Ras and ERK activation assays\",\n      \"journal\": \"Translational research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — siRNA plus pharmacological controls defining PTH→PLC→RasGRP1→ERK→NCC pathway\",\n      \"pmids\": [\"22005268\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RASGRP1 is a DAG/Ca2+-regulated Ras guanine nucleotide exchange factor that, upon membrane recruitment via its C1 (DAG-binding), PT, and EF-hand domains (regulated by PI3K-generated phosphoinositides), activates Ras at the plasma membrane and Golgi to drive ERK/MAPK signaling; in lymphocytes it is essential for TCR/BCR-triggered Ras-ERK activation (acting upstream of and in positive feedback with SOS), thymocyte development, and NK/mast cell effector functions, while its autoinhibition involves an interdomain linker blocking the Ras-binding site and a dimerization interface masking the membrane-interaction surface, both relieved by Ca2+ and membrane-localization signals.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"RASGRP1 is a diacylglycerol (DAG)- and calcium-regulated guanine nucleotide exchange factor (GEF) for Ras family GTPases that couples receptor-generated lipid second messengers to Ras-ERK/MAPK signaling, with essential roles in lymphocyte development, immune effector function, and neuronal signaling. Membrane recruitment is governed by cooperative engagement of its C1 domain with DAG, a plasma membrane-targeting (PT) domain that senses PI3K-generated phosphoinositides, and EF-hand–mediated conformational changes; autoinhibition involves an interdomain linker occluding the Ras-binding site and a dimerization interface masking the membrane-interaction surface, both relieved by Ca²⁺ and membrane localization [PMID:9582122, PMID:23908768, PMID:21285350, PMID:17567957]. In T and B cells, RASGRP1 is the dominant Ras GEF downstream of antigen receptor–activated PLCγ, and it primes SOS-mediated positive feedback amplification of Ras-GTP; loss of RASGRP1 blocks thymocyte positive selection, impairs NK cell cytotoxicity, abolishes mast cell degranulation, and causes human immunodeficiency [PMID:11017103, PMID:17283063, PMID:27776107, PMID:17190838]. Beyond classical Ras, RASGRP1 acts as a GEF for Rheb to activate mTOR signaling in striatal neurons, where it is a causal mediator of L-DOPA–induced dyskinesia [PMID:32426479].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Identification of RASGRP1 as a DAG-responsive Ras GEF resolved how lipid second messengers directly activate Ras independently of receptor tyrosine kinase–SOS pathways, establishing a new signaling paradigm.\",\n      \"evidence\": \"cDNA characterization, domain deletion mutagenesis, cellular fractionation, Ras-ERK assays, and fibroblast transformation assays\",\n      \"pmids\": [\"9582122\", \"9819387\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous substrates beyond H-Ras not yet defined\", \"Regulation by calcium through EF hands not yet mechanistically resolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Genetic knockout and antibody-inhibition studies established that RASGRP1 is the essential Ras GEF linking TCR/PLCγ1–generated DAG to Ras-ERK activation in thymocytes, explaining the long-standing gap between TCR engagement and Ras activation.\",\n      \"evidence\": \"RasGRP1-null mice with thymocyte phenotyping; inhibitory antibodies and PLCγ1 inhibitors in Jurkat T cells; high-affinity C1 domain binding measured by radioligand assay\",\n      \"pmids\": [\"11017103\", \"10807788\", \"10779365\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether RASGRP1 and SOS cooperate or compete in physiological TCR signaling unknown\", \"Compartment-specific Ras activation not yet explored\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Discovery that RASGRP1 activates Ras specifically at the Golgi apparatus (and not plasma membrane) after TCR stimulation revealed that Ras signaling is compartmentalized, with Ca²⁺ positively regulating Golgi-Ras and negatively regulating plasma membrane-Ras.\",\n      \"evidence\": \"Live-cell imaging of RASGRP1 translocation, compartment-specific Ras activation assays, Ca²⁺ manipulation in Jurkat T cells; systematic GEF comparison across compartments\",\n      \"pmids\": [\"12845332\", \"12782630\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How DAG and Ca²⁺ signals are spatially segregated between Golgi and plasma membrane not fully resolved\", \"Functional consequences of Golgi-specific vs. plasma membrane Ras signaling on downstream gene expression unclear\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"RASGRP1 was shown to promote BCR-induced apoptosis in immature B cells through NF-κB/Bcl-xL downregulation independently of ERK, revealing a pro-apoptotic function relevant to B cell tolerance.\",\n      \"evidence\": \"Overexpression and dominant-negative mutant of RasGRP1, NF-κB reporter assays, Bcl-xL immunoblot, apoptosis assays in WEHI-231 B cells\",\n      \"pmids\": [\"14970203\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The Ras-independent mechanism by which RASGRP1 suppresses NF-κB not identified\", \"Physiological relevance to in vivo B cell selection not tested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Phosphorylation of Thr184 by novel PKCs was identified as a key regulatory input, and DAG-PKC-RASGRP1 was placed as a pathway parallel to SOS, resolving how two distinct GEF arms cooperate downstream of TCR.\",\n      \"evidence\": \"RasGRP1-deficient Jurkat clone, RNAi, domain mutagenesis, phosphorylation mapping, ERK activation assays\",\n      \"pmids\": [\"15899849\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for PKC-mediated Thr184 phosphorylation effect unknown\", \"Whether Thr184 phosphorylation is required in vivo not tested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"The discovery that RASGRP1-generated Ras-GTP primes the allosteric site of SOS established a positive-feedback amplification loop, explaining why RASGRP1 dominates over SOS in lymphocyte Ras activation and providing a mechanistic basis for digital/analog Ras signaling responses.\",\n      \"evidence\": \"SOS allosteric mutants, RasGTP measurement, RasV12C40 rescue in T and B cell lines\",\n      \"pmids\": [\"17283063\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative parameters of the feedback loop (thresholds, kinetics) not measured in primary cells\", \"Whether this loop operates identically in B versus T cells unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Systematic domain dissection in B cells identified the PT domain as essential for plasma membrane targeting and the SuPT domain as an intramolecular brake, establishing that RASGRP1 membrane recruitment requires cooperative relief of autoinhibition by DAG and the PT/EF-hand modules.\",\n      \"evidence\": \"Domain deletion/mutation analysis, live-cell imaging of RASGRP1 translocation after BCR ligation in B cell lines; Vav1 KO epistasis defining upstream pathway\",\n      \"pmids\": [\"17567957\", \"14764585\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of SuPT-mediated inhibition not resolved at atomic level\", \"Whether SuPT regulation differs between T and B cells not tested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Beyond immune cells, RASGRP1 was found to mediate phorbol ester– and PTH-induced suppression of the renal sodium-chloride cotransporter NCC via H-Ras-ERK signaling, expanding RASGRP1 function to epithelial ion transport regulation.\",\n      \"evidence\": \"RasGRP1 siRNA, thiazide-sensitive ²²Na⁺ uptake, H-Ras and ERK assays, PKC inhibitor controls in mDCT cells\",\n      \"pmids\": [\"18077438\", \"20392800\", \"22005268\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether RASGRP1 regulation of NCC is physiologically relevant in vivo not demonstrated\", \"Mechanism connecting ERK activation to NCC ubiquitination not fully defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"PI3K-generated phosphoinositides were identified as direct ligands of the RASGRP1 PT domain, establishing a novel PI3K-RAS signaling cross-talk mechanism that cooperates with DAG sensing for membrane targeting.\",\n      \"evidence\": \"Phospholipid vesicle binding assay, PI3K inhibition, point mutagenesis of basic/hydrophobic cluster, subcellular localization in B cells\",\n      \"pmids\": [\"21285350\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which specific phosphoinositide species are preferred in vivo not determined\", \"Whether PI3K-PT interaction is regulated by Ca²⁺ or phosphorylation unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"A Ca²⁺-driven, PKCδ-dependent pathway through RASGRP1 was shown to activate proapoptotic ERK signaling during B cell development, distinguishing Ca²⁺-triggered from DAG-triggered RASGRP1 activation modes and linking RASGRP1 to B cell negative selection.\",\n      \"evidence\": \"PKCδ knockout mice, STIM1 overexpression, Ca²⁺ flux manipulation, ERK assays in developing B cells\",\n      \"pmids\": [\"21441934\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Ca²⁺ and PKCδ mechanistically converge on RASGRP1 at the molecular level unclear\", \"Whether this pathway operates in human B cell development not tested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"The crystal structure of autoinhibited RASGRP1 revealed the atomic mechanism of autoinhibition: an interdomain linker blocks the Ras-binding site and dimerization buries the membrane-interaction surface; Ca²⁺ binding induces conformational changes incompatible with this inactive assembly, providing a structural framework for activation.\",\n      \"evidence\": \"X-ray crystallography, NMR spectroscopy, functional domain mutagenesis\",\n      \"pmids\": [\"23908768\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of the fully active, membrane-bound RASGRP1-Ras complex not determined\", \"How DAG binding cooperates structurally with Ca²⁺-induced conformational change not visualized\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"In intestinal epithelial cells, RASGRP1 was found to oppose SOS1-driven proliferative Ras-ERK signaling, functioning as a negative feedback regulator downstream of EGFR — a role opposite to its activating function in lymphocytes — with genetic depletion exacerbating tumorigenesis in KRas and Apc mutant mice.\",\n      \"evidence\": \"RasGRP1 knockout mice crossed with KRas and Apc mutant mice, Ras-ERK signaling and proliferation assays in intestinal crypts\",\n      \"pmids\": [\"26005835\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis for how RASGRP1 generates negative feedback (competition with SOS, substrate selectivity?) not defined\", \"Whether this tumor-suppressive role extends to other epithelia unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Human RASGRP1 deficiency was identified as a cause of combined immunodeficiency, with impaired T cell, B cell, and NK cell function including defective ERK phosphorylation and granule convergence; DYNLL1 was identified as a physical interactor linking RASGRP1 to cytoskeletal dynamics and RhoA activation.\",\n      \"evidence\": \"Homozygosity mapping, exome sequencing, wild-type rescue, interaction proteomics, RhoA activation and NK cytotoxicity assays\",\n      \"pmids\": [\"27776107\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full spectrum of clinical phenotype across patients not established\", \"Mechanism by which RASGRP1-DYNLL1 interaction regulates granule convergence not resolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"His212 was identified as a pH sensor controlling the balance between autoinhibited and active conformations, providing a structural mechanism for environmental pH regulation of RASGRP1 signaling.\",\n      \"evidence\": \"SNP variant analysis, crystal structure comparison with active RasGRP4:H-Ras complex, plasma membrane recruitment and signaling assays with His212 mutants\",\n      \"pmids\": [\"28952923\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological contexts where pH fluctuations regulate RASGRP1 not identified\", \"Whether pH sensing cooperates with Ca²⁺ and DAG inputs not tested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"RUNX1/CBFB was established as a direct transcriptional regulator of RASGRP1 through an intronic enhancer harboring autoimmunity-associated SNPs, connecting genetic risk for SLE to RASGRP1 expression levels in T cells.\",\n      \"evidence\": \"CRISPR-Cas9 enhancer disruption, EMSA, ChIP-qPCR, mass spectrometry identifying hnRNP-K, luciferase reporters in Jurkat and primary T cells; mouse models with graded Rasgrp1 expression\",\n      \"pmids\": [\"31164884\", \"33065764\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether additional transcription factors beyond RUNX1 and hnRNP-K regulate this enhancer unknown\", \"Causal link from SNP to SLE pathogenesis through RASGRP1 dosage not demonstrated in patients\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"RASGRP1 was shown to function as a GEF for Rheb (in addition to Ras), activating mTOR signaling in striatal neurons and causally driving L-DOPA–induced dyskinesia, extending RASGRP1 substrate range beyond classical Ras GTPases.\",\n      \"evidence\": \"RasGRP1 knockout mice and macaque PD models, L-DOPA dyskinesia scoring, ERK and mTOR signaling assays, mass spectrometry\",\n      \"pmids\": [\"32426479\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Biochemical GEF activity toward Rheb not reconstituted in vitro with purified proteins\", \"Whether Rheb is a physiological substrate in immune cells not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the full-length structure of active membrane-bound RASGRP1 in complex with Ras, the quantitative integration of DAG/Ca²⁺/PI3K/pH inputs into a unified activation model, the molecular basis for context-dependent tumor-suppressive versus oncogenic roles, and whether Rheb GEF activity is a general or tissue-specific function.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structure of full-length active RASGRP1 on membranes\", \"Quantitative signaling model integrating all regulatory inputs absent\", \"Rheb GEF activity not biochemically reconstituted in vitro\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 2, 10, 28]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [0, 4, 14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [5, 6, 20]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 12, 14, 20]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 2, 5, 9, 10, 15, 28, 29, 31]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3, 11, 17, 24, 33]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [15, 25, 36]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [3, 26]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"SOS1\",\n      \"DYNLL1\",\n      \"RHES\",\n      \"SKAP55\",\n      \"HSP90\",\n      \"ZAP70\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}